PANTHER GO-Slim Biological Process	background_genes.cra_all.raisd.txt - REFLIST (11273)	(136)	(expected)	(over/under)	(fold Enrichment)	P-value
platelet aggregation (GO:0070527)	4	4	.05	+	82.89	2.03E-08
mononuclear cell proliferation (GO:0032943)	1	1	.01	+	82.89	1.21E-02
lymphocyte proliferation (GO:0046651)	1	1	.01	+	82.89	1.21E-02
leukocyte proliferation (GO:0070661)	1	1	.01	+	82.89	1.21E-02
retinol metabolic process (GO:0042572)	1	1	.01	+	82.89	1.21E-02
platelet activation (GO:0030168)	5	4	.06	+	66.31	1.00E-07
protein activation cascade (GO:0072376)	5	4	.06	+	66.31	1.00E-07
negative regulation of blood coagulation (GO:0030195)	4	3	.05	+	62.17	6.81E-06
homotypic cell-cell adhesion (GO:0034109)	6	4	.07	+	55.26	2.98E-07
negative regulation of coagulation (GO:0050819)	5	3	.06	+	49.73	1.69E-05
regulation of response to wounding (GO:1903034)	6	3	.07	+	41.44	3.35E-05
hemostasis (GO:0007599)	8	4	.10	+	41.44	1.37E-06
blood coagulation (GO:0007596)	8	4	.10	+	41.44	1.37E-06
glycogen biosynthetic process (GO:0005978)	2	1	.02	+	41.44	2.40E-02
DNA methylation-dependent heterochromatin formation (GO:0006346)	2	1	.02	+	41.44	2.40E-02
coagulation (GO:0050817)	8	4	.10	+	41.44	1.37E-06
regulation of wound healing (GO:0061041)	6	3	.07	+	41.44	3.35E-05
glucan biosynthetic process (GO:0009250)	2	1	.02	+	41.44	2.40E-02
regulation of coagulation (GO:0050818)	7	3	.08	+	35.52	5.80E-05
regulation of body fluid levels (GO:0050878)	11	4	.13	+	30.14	6.26E-06
telomere capping (GO:0016233)	3	1	.04	+	27.63	3.58E-02
DNA methylation (GO:0006306)	3	1	.04	+	27.63	3.58E-02
DNA alkylation (GO:0006305)	3	1	.04	+	27.63	3.58E-02
positive regulation of cell-cell adhesion (GO:0022409)	9	3	.11	+	27.63	1.37E-04
polysaccharide biosynthetic process (GO:0000271)	7	2	.08	+	23.68	2.92E-03
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	4	1	.05	+	20.72	4.74E-02
B cell differentiation (GO:0030183)	4	1	.05	+	20.72	4.74E-02
retinoid metabolic process (GO:0001523)	4	1	.05	+	20.72	4.74E-02
diterpenoid metabolic process (GO:0016101)	4	1	.05	+	20.72	4.74E-02
feeding behavior (GO:0007631)	4	1	.05	+	20.72	4.74E-02
cell activation (GO:0001775)	25	6	.30	+	19.89	4.05E-07
wound healing (GO:0042060)	17	4	.21	+	19.50	4.27E-05
response to wounding (GO:0009611)	23	5	.28	+	18.02	6.71E-06
regulation of cell-cell adhesion (GO:0022407)	14	3	.17	+	17.76	5.67E-04
post-translational protein targeting to membrane, translocation (GO:0031204)	5	1	.06	+	16.58	5.89E-02
positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	5	1	.06	+	16.58	5.89E-02
regulation of cell adhesion mediated by integrin (GO:0033628)	5	1	.06	+	16.58	5.89E-02
negative regulation of response to external stimulus (GO:0032102)	15	3	.18	+	16.58	7.03E-04
Golgi to vacuole transport (GO:0006896)	5	1	.06	+	16.58	5.89E-02
polysaccharide metabolic process (GO:0005976)	11	2	.13	+	15.07	7.40E-03
energy reserve metabolic process (GO:0006112)	6	1	.07	+	13.81	7.03E-02
heterochromatin formation (GO:0031507)	18	3	.22	+	13.81	1.23E-03
terpenoid metabolic process (GO:0006721)	6	1	.07	+	13.81	7.03E-02
autophagosome maturation (GO:0097352)	6	1	.07	+	13.81	7.03E-02
glycogen metabolic process (GO:0005977)	6	1	.07	+	13.81	7.03E-02
telomere maintenance via telomere lengthening (GO:0010833)	6	1	.07	+	13.81	7.03E-02
dorsal/ventral pattern formation (GO:0009953)	6	1	.07	+	13.81	7.03E-02
post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	6	1	.07	+	13.81	7.03E-02
zymogen activation (GO:0031638)	6	1	.07	+	13.81	7.03E-02
glucan metabolic process (GO:0044042)	6	1	.07	+	13.81	7.03E-02
cyclic nucleotide metabolic process (GO:0009187)	7	1	.08	+	11.84	8.15E-02
positive regulation of cell adhesion (GO:0045785)	21	3	.25	+	11.84	1.95E-03
regulation of transcription elongation by RNA polymerase II (GO:0034243)	7	1	.08	+	11.84	8.15E-02
calcineurin-mediated signaling (GO:0097720)	7	1	.08	+	11.84	8.15E-02
B cell activation (GO:0042113)	7	1	.08	+	11.84	8.15E-02
cell population proliferation (GO:0008283)	7	1	.08	+	11.84	8.15E-02
positive regulation of actin filament bundle assembly (GO:0032233)	7	1	.08	+	11.84	8.15E-02
kidney development (GO:0001822)	7	1	.08	+	11.84	8.15E-02
positive regulation of DNA-templated transcription, elongation (GO:0032786)	7	1	.08	+	11.84	8.15E-02
behavior (GO:0007610)	7	1	.08	+	11.84	8.15E-02
heterochromatin organization (GO:0070828)	22	3	.27	+	11.30	2.24E-03
smoothened signaling pathway (GO:0007224)	15	2	.18	+	11.05	1.37E-02
lymphocyte activation (GO:0046649)	15	2	.18	+	11.05	1.37E-02
phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491)	8	1	.10	+	10.36	9.26E-02
receptor clustering (GO:0043113)	8	1	.10	+	10.36	9.26E-02
centrosome localization (GO:0051642)	8	1	.10	+	10.36	9.26E-02
carbohydrate biosynthetic process (GO:0016051)	16	2	.19	+	10.36	1.55E-02
negative regulation of gene expression, epigenetic (GO:0045814)	24	3	.29	+	10.36	2.89E-03
synaptic vesicle endocytosis (GO:0048488)	26	3	.31	+	9.56	3.64E-03
synaptic vesicle recycling (GO:0036465)	27	3	.33	+	9.21	4.06E-03
intracellular pH reduction (GO:0051452)	9	1	.11	+	9.21	1.04E-01
neuromuscular junction development (GO:0007528)	9	1	.11	+	9.21	1.04E-01
leukocyte activation (GO:0045321)	18	2	.22	+	9.21	1.95E-02
DNA modification (GO:0006304)	9	1	.11	+	9.21	1.04E-01
vacuolar acidification (GO:0007035)	9	1	.11	+	9.21	1.04E-01
synaptic vesicle transport (GO:0048489)	9	1	.11	+	9.21	1.04E-01
pyrimidine nucleobase metabolic process (GO:0006206)	9	1	.11	+	9.21	1.04E-01
nucleobase metabolic process (GO:0009112)	19	2	.23	+	8.73	2.16E-02
regulation of cell adhesion (GO:0030155)	38	4	.46	+	8.73	1.09E-03
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	20	2	.24	+	8.29	2.38E-02
purine nucleobase metabolic process (GO:0006144)	10	1	.12	+	8.29	1.14E-01
lymphocyte differentiation (GO:0030098)	10	1	.12	+	8.29	1.14E-01
regulation of actin filament bundle assembly (GO:0032231)	10	1	.12	+	8.29	1.14E-01
epigenetic regulation of gene expression (GO:0040029)	30	3	.36	+	8.29	5.50E-03
regulation of DNA-templated transcription elongation (GO:0032784)	10	1	.12	+	8.29	1.14E-01
COPII-coated vesicle budding (GO:0090114)	10	1	.12	+	8.29	1.14E-01
protein targeting to ER (GO:0045047)	11	1	.13	+	7.54	1.25E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	11	1	.13	+	7.54	1.25E-01
clathrin-dependent endocytosis (GO:0072583)	11	1	.13	+	7.54	1.25E-01
protein targeting to vacuole (GO:0006623)	11	1	.13	+	7.54	1.25E-01
negative regulation of multicellular organismal process (GO:0051241)	33	3	.40	+	7.54	7.19E-03
mononuclear cell differentiation (GO:1903131)	11	1	.13	+	7.54	1.25E-01
cellular response to starvation (GO:0009267)	23	2	.28	+	7.21	3.10E-02
vesicle budding from membrane (GO:0006900)	24	2	.29	+	6.91	3.35E-02
pyrimidine nucleotide metabolic process (GO:0006220)	12	1	.14	+	6.91	1.36E-01
cellular response to nutrient levels (GO:0031669)	24	2	.29	+	6.91	3.35E-02
cellular response to extracellular stimulus (GO:0031668)	24	2	.29	+	6.91	3.35E-02
mRNA destabilization (GO:0061157)	25	2	.30	+	6.63	3.62E-02
cellular response to external stimulus (GO:0071496)	25	2	.30	+	6.63	3.62E-02
RNA destabilization (GO:0050779)	25	2	.30	+	6.63	3.62E-02
hormone metabolic process (GO:0042445)	13	1	.16	+	6.38	1.46E-01
substrate adhesion-dependent cell spreading (GO:0034446)	13	1	.16	+	6.38	1.46E-01
isoprenoid metabolic process (GO:0006720)	14	1	.17	+	5.92	1.56E-01
positive regulation of mRNA catabolic process (GO:0061014)	28	2	.34	+	5.92	4.45E-02
leukocyte differentiation (GO:0002521)	15	1	.18	+	5.53	1.67E-01
response to starvation (GO:0042594)	30	2	.36	+	5.53	5.04E-02
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	15	1	.18	+	5.53	1.67E-01
synaptic vesicle cycle (GO:0099504)	47	3	.57	+	5.29	1.89E-02
regulation of response to external stimulus (GO:0032101)	47	3	.57	+	5.29	1.89E-02
vesicle-mediated transport in synapse (GO:0099003)	47	3	.57	+	5.29	1.89E-02
establishment or maintenance of bipolar cell polarity (GO:0061245)	16	1	.19	+	5.18	1.77E-01
phosphatidylinositol phosphate biosynthetic process (GO:0046854)	32	2	.39	+	5.18	5.66E-02
positive regulation of mRNA metabolic process (GO:1903313)	32	2	.39	+	5.18	5.66E-02
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	16	1	.19	+	5.18	1.77E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	16	1	.19	+	5.18	1.77E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088)	16	1	.19	+	5.18	1.77E-01
import into nucleus (GO:0051170)	34	2	.41	+	4.88	6.31E-02
response to extracellular stimulus (GO:0009991)	34	2	.41	+	4.88	6.31E-02
protein import into nucleus (GO:0006606)	34	2	.41	+	4.88	6.31E-02
intracellular protein transmembrane transport (GO:0065002)	17	1	.21	+	4.88	1.87E-01
response to nutrient levels (GO:0031667)	34	2	.41	+	4.88	6.31E-02
macroautophagy (GO:0016236)	52	3	.63	+	4.78	2.47E-02
autophagy of mitochondrion (GO:0000422)	35	2	.42	+	4.74	6.64E-02
ribonucleotide biosynthetic process (GO:0009260)	35	2	.42	+	4.74	6.64E-02
vacuolar transport (GO:0007034)	57	3	.69	+	4.36	3.13E-02
ribose phosphate biosynthetic process (GO:0046390)	38	2	.46	+	4.36	7.66E-02
release of sequestered calcium ion into cytosol (GO:0051209)	19	1	.23	+	4.36	2.06E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	39	2	.47	+	4.25	8.02E-02
protein localization to nucleus (GO:0034504)	40	2	.48	+	4.14	8.37E-02
establishment of protein localization to vacuole (GO:0072666)	20	1	.24	+	4.14	2.16E-01
autophagy (GO:0006914)	61	3	.74	+	4.08	3.72E-02
process utilizing autophagic mechanism (GO:0061919)	61	3	.74	+	4.08	3.72E-02
cell-substrate adhesion (GO:0031589)	42	2	.51	+	3.95	9.10E-02
mRNA catabolic process (GO:0006402)	42	2	.51	+	3.95	9.10E-02
regulation of hormone levels (GO:0010817)	21	1	.25	+	3.95	2.25E-01
autophagosome assembly (GO:0000045)	42	2	.51	+	3.95	9.10E-02
negative regulation of sequestering of calcium ion (GO:0051283)	21	1	.25	+	3.95	2.25E-01
negative regulation of gene expression (GO:0010629)	108	5	1.30	+	3.84	9.82E-03
regulation of intracellular pH (GO:0051453)	22	1	.27	+	3.77	2.35E-01
protein localization to vacuole (GO:0072665)	22	1	.27	+	3.77	2.35E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	22	1	.27	+	3.77	2.35E-01
protein localization to endoplasmic reticulum (GO:0070972)	22	1	.27	+	3.77	2.35E-01
endocytosis (GO:0006897)	110	5	1.33	+	3.77	1.06E-02
positive regulation of kinase activity (GO:0033674)	67	3	.81	+	3.71	4.71E-02
organelle disassembly (GO:1903008)	45	2	.54	+	3.68	1.02E-01
positive regulation of cellular catabolic process (GO:0031331)	45	2	.54	+	3.68	1.02E-01
positive regulation of transferase activity (GO:0051347)	68	3	.82	+	3.66	4.88E-02
regulation of response to stress (GO:0080134)	68	3	.82	+	3.66	4.88E-02
proteoglycan biosynthetic process (GO:0030166)	23	1	.28	+	3.60	2.44E-01
RNA catabolic process (GO:0006401)	46	2	.55	+	3.60	1.06E-01
regulation of mRNA stability (GO:0043488)	46	2	.55	+	3.60	1.06E-01
regulation of RNA stability (GO:0043487)	46	2	.55	+	3.60	1.06E-01
regulation of cellular pH (GO:0030641)	23	1	.28	+	3.60	2.44E-01
regulation of pH (GO:0006885)	23	1	.28	+	3.60	2.44E-01
telomere maintenance (GO:0000723)	24	1	.29	+	3.45	2.53E-01
telomere organization (GO:0032200)	24	1	.29	+	3.45	2.53E-01
phosphatidylinositol biosynthetic process (GO:0006661)	48	2	.58	+	3.45	1.14E-01
pyrimidine-containing compound metabolic process (GO:0072527)	24	1	.29	+	3.45	2.53E-01
regulation of mRNA catabolic process (GO:0061013)	49	2	.59	+	3.38	1.18E-01
protein processing (GO:0016485)	50	2	.60	+	3.32	1.22E-01
macromolecule methylation (GO:0043414)	50	2	.60	+	3.32	1.22E-01
methylation (GO:0032259)	50	2	.60	+	3.32	1.22E-01
regulation of sequestering of calcium ion (GO:0051282)	25	1	.30	+	3.32	2.62E-01
tRNA processing (GO:0008033)	51	2	.62	+	3.25	1.26E-01
protein maturation (GO:0051604)	155	6	1.87	+	3.21	1.12E-02
hemopoiesis (GO:0030097)	26	1	.31	+	3.19	2.71E-01
protein targeting to membrane (GO:0006612)	26	1	.31	+	3.19	2.71E-01
regulation of exocytosis (GO:0017157)	26	1	.31	+	3.19	2.71E-01
neural crest cell migration (GO:0001755)	26	1	.31	+	3.19	2.71E-01
establishment of protein localization to organelle (GO:0072594)	107	4	1.29	+	3.10	4.04E-02
proteoglycan metabolic process (GO:0006029)	27	1	.33	+	3.07	2.80E-01
receptor-mediated endocytosis (GO:0006898)	27	1	.33	+	3.07	2.80E-01
regulation of mRNA metabolic process (GO:1903311)	82	3	.99	+	3.03	7.65E-02
neural crest cell differentiation (GO:0014033)	28	1	.34	+	2.96	2.88E-01
neural crest cell development (GO:0014032)	28	1	.34	+	2.96	2.88E-01
neuropeptide signaling pathway (GO:0007218)	28	1	.34	+	2.96	2.88E-01
translational initiation (GO:0006413)	28	1	.34	+	2.96	2.88E-01
cell-matrix adhesion (GO:0007160)	28	1	.34	+	2.96	2.88E-01
protein transmembrane transport (GO:0071806)	28	1	.34	+	2.96	2.88E-01
tRNA metabolic process (GO:0006399)	84	3	1.01	+	2.96	8.10E-02
stem cell development (GO:0048864)	28	1	.34	+	2.96	2.88E-01
stem cell differentiation (GO:0048863)	28	1	.34	+	2.96	2.88E-01
calcium ion transmembrane import into cytosol (GO:0097553)	28	1	.34	+	2.96	2.88E-01
cell-cell adhesion (GO:0098609)	142	5	1.71	+	2.92	2.86E-02
nucleotide biosynthetic process (GO:0009165)	57	2	.69	+	2.91	1.51E-01
nucleoside phosphate biosynthetic process (GO:1901293)	58	2	.70	+	2.86	1.55E-01
chromatin remodeling (GO:0006338)	88	3	1.06	+	2.83	9.01E-02
vacuole organization (GO:0007033)	59	2	.71	+	2.81	1.59E-01
mesenchyme development (GO:0060485)	30	1	.36	+	2.76	3.06E-01
purine ribonucleotide biosynthetic process (GO:0009152)	30	1	.36	+	2.76	3.06E-01
calcium-mediated signaling (GO:0019722)	30	1	.36	+	2.76	3.06E-01
mesenchymal cell differentiation (GO:0048762)	30	1	.36	+	2.76	3.06E-01
cell adhesion (GO:0007155)	211	7	2.55	+	2.75	1.40E-02
vesicle organization (GO:0016050)	91	3	1.10	+	2.73	9.73E-02
protein targeting (GO:0006605)	61	2	.74	+	2.72	1.68E-01
regulation of mRNA splicing, via spliceosome (GO:0048024)	31	1	.37	+	2.67	3.14E-01
glycerophospholipid biosynthetic process (GO:0046474)	63	2	.76	+	2.63	1.76E-01
chromatin organization (GO:0006325)	95	3	1.15	+	2.62	1.07E-01
establishment of vesicle localization (GO:0051650)	32	1	.39	+	2.59	3.22E-01
energy derivation by oxidation of organic compounds (GO:0015980)	32	1	.39	+	2.59	3.22E-01
protein localization to membrane (GO:0072657)	98	3	1.18	+	2.54	1.15E-01
monocarboxylic acid transport (GO:0015718)	33	1	.40	+	2.51	3.30E-01
vesicle localization (GO:0051648)	33	1	.40	+	2.51	3.30E-01
positive regulation of catabolic process (GO:0009896)	66	2	.80	+	2.51	1.89E-01
cytokine-mediated signaling pathway (GO:0019221)	34	1	.41	+	2.44	3.39E-01
post-Golgi vesicle-mediated transport (GO:0006892)	34	1	.41	+	2.44	3.39E-01
organophosphate biosynthetic process (GO:0090407)	137	4	1.65	+	2.42	8.39E-02
ameboidal-type cell migration (GO:0001667)	35	1	.42	+	2.37	3.47E-01
phospholipid biosynthetic process (GO:0008654)	70	2	.84	+	2.37	2.07E-01
regulation of protein localization (GO:0032880)	35	1	.42	+	2.37	3.47E-01
ribonucleotide metabolic process (GO:0009259)	70	2	.84	+	2.37	2.07E-01
import into cell (GO:0098657)	177	5	2.14	+	2.34	6.30E-02
carbohydrate metabolic process (GO:0005975)	71	2	.86	+	2.33	2.11E-01
positive regulation of phosphorylation (GO:0042327)	107	3	1.29	+	2.32	1.39E-01
regulation of mRNA processing (GO:0050684)	36	1	.43	+	2.30	3.54E-01
glycerolipid biosynthetic process (GO:0045017)	72	2	.87	+	2.30	2.16E-01
organic hydroxy compound metabolic process (GO:1901615)	72	2	.87	+	2.30	2.16E-01
nuclear transport (GO:0051169)	73	2	.88	+	2.27	2.20E-01
nucleocytoplasmic transport (GO:0006913)	73	2	.88	+	2.27	2.20E-01
positive regulation of phosphorus metabolic process (GO:0010562)	111	3	1.34	+	2.24	1.50E-01
positive regulation of phosphate metabolic process (GO:0045937)	111	3	1.34	+	2.24	1.50E-01
regionalization (GO:0003002)	37	1	.45	+	2.24	3.62E-01
protein-DNA complex organization (GO:0071824)	113	3	1.36	+	2.20	1.56E-01
ribose phosphate metabolic process (GO:0019693)	76	2	.92	+	2.18	2.33E-01
cellular response to cytokine stimulus (GO:0071345)	38	1	.46	+	2.18	3.70E-01
intracellular protein transport (GO:0006886)	154	4	1.86	+	2.15	1.16E-01
protein-containing complex disassembly (GO:0032984)	39	1	.47	+	2.13	3.78E-01
regulation of kinase activity (GO:0043549)	119	3	1.44	+	2.09	1.74E-01
regulation of secretion by cell (GO:1903530)	40	1	.48	+	2.07	3.85E-01
cellular component disassembly (GO:0022411)	80	2	.97	+	2.07	2.51E-01
ribosomal large subunit biogenesis (GO:0042273)	40	1	.48	+	2.07	3.85E-01
regulation of transferase activity (GO:0051338)	122	3	1.47	+	2.04	1.83E-01
regulation of secretion (GO:0051046)	41	1	.49	+	2.02	3.93E-01
vesicle fusion (GO:0006906)	41	1	.49	+	2.02	3.93E-01
regulation of multicellular organismal process (GO:0051239)	166	4	2.00	+	2.00	1.41E-01
phosphatidylinositol metabolic process (GO:0046488)	84	2	1.01	+	1.97	2.69E-01
amino acid transmembrane transport (GO:0003333)	42	1	.51	+	1.97	4.00E-01
organelle membrane fusion (GO:0090174)	42	1	.51	+	1.97	4.00E-01
positive regulation of cellular component biogenesis (GO:0044089)	42	1	.51	+	1.97	4.00E-01
protein localization to organelle (GO:0033365)	170	4	2.05	+	1.95	1.50E-01
positive regulation of organelle organization (GO:0010638)	43	1	.52	+	1.93	4.07E-01
regulation of biological quality (GO:0065008)	388	9	4.68	+	1.92	5.34E-02
nucleobase-containing compound catabolic process (GO:0034655)	88	2	1.06	+	1.88	2.87E-01
purine nucleotide biosynthetic process (GO:0006164)	45	1	.54	+	1.84	4.21E-01
regulation of cellular localization (GO:0060341)	45	1	.54	+	1.84	4.21E-01
response to cytokine (GO:0034097)	45	1	.54	+	1.84	4.21E-01
regulation of cellular catabolic process (GO:0031329)	91	2	1.10	+	1.82	3.01E-01
nucleobase-containing small molecule metabolic process (GO:0055086)	137	3	1.65	+	1.82	2.29E-01
pattern specification process (GO:0007389)	46	1	.55	+	1.80	4.28E-01
localization within membrane (GO:0051668)	140	3	1.69	+	1.78	2.39E-01
vesicle-mediated transport (GO:0016192)	421	9	5.08	+	1.77	1.03E-01
heart development (GO:0007507)	47	1	.57	+	1.76	4.35E-01
establishment of localization in cell (GO:0051649)	474	10	5.72	+	1.75	8.03E-02
purine-containing compound metabolic process (GO:0072521)	95	2	1.15	+	1.75	3.18E-01
lipoprotein biosynthetic process (GO:0042158)	48	1	.58	+	1.73	4.42E-01
post-transcriptional regulation of gene expression (GO:0010608)	96	2	1.16	+	1.73	3.23E-01
protein lipidation (GO:0006497)	48	1	.58	+	1.73	4.42E-01
establishment or maintenance of cell polarity (GO:0007163)	48	1	.58	+	1.73	4.42E-01
membrane fusion (GO:0061025)	48	1	.58	+	1.73	4.42E-01
negative regulation of programmed cell death (GO:0043069)	48	1	.58	+	1.73	4.42E-01
carboxylic acid transport (GO:0046942)	96	2	1.16	+	1.73	3.23E-01
organic acid transport (GO:0015849)	96	2	1.16	+	1.73	3.23E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	97	2	1.17	+	1.71	3.27E-01
positive regulation of catalytic activity (GO:0043085)	146	3	1.76	+	1.70	2.58E-01
membrane organization (GO:0061024)	147	3	1.77	+	1.69	2.61E-01
glycosylation (GO:0070085)	98	2	1.18	+	1.69	3.32E-01
establishment of protein localization to membrane (GO:0090150)	49	1	.59	+	1.69	4.49E-01
cellular localization (GO:0051641)	693	14	8.36	+	1.67	4.84E-02
purine-containing compound biosynthetic process (GO:0072522)	50	1	.60	+	1.66	4.56E-01
nucleotide metabolic process (GO:0009117)	101	2	1.22	+	1.64	3.45E-01
cellular macromolecule localization (GO:0070727)	406	8	4.90	+	1.63	1.58E-01
protein localization (GO:0008104)	406	8	4.90	+	1.63	1.58E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	254	5	3.06	+	1.63	2.37E-01
protein-containing complex localization (GO:0031503)	51	1	.62	+	1.63	4.62E-01
cellular nitrogen compound catabolic process (GO:0044270)	102	2	1.23	+	1.63	3.49E-01
heterocycle catabolic process (GO:0046700)	102	2	1.23	+	1.63	3.49E-01
alcohol metabolic process (GO:0006066)	51	1	.62	+	1.63	4.62E-01
protein transport (GO:0015031)	204	4	2.46	+	1.63	3.15E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	51	1	.62	+	1.63	4.62E-01
negative regulation of biosynthetic process (GO:0009890)	256	5	3.09	+	1.62	2.40E-01
negative regulation of cellular biosynthetic process (GO:0031327)	256	5	3.09	+	1.62	2.40E-01
negative regulation of transcription by RNA polymerase II (GO:0000122)	103	2	1.24	+	1.61	3.54E-01
mitochondrion organization (GO:0007005)	103	2	1.24	+	1.61	3.54E-01
organic acid transmembrane transport (GO:1903825)	52	1	.63	+	1.59	4.69E-01
carboxylic acid transmembrane transport (GO:1905039)	52	1	.63	+	1.59	4.69E-01
multicellular organismal process (GO:0032501)	782	15	9.43	+	1.59	8.59E-02
immune system process (GO:0002376)	106	2	1.28	+	1.56	3.67E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	159	3	1.92	+	1.56	4.44E-01
organelle fusion (GO:0048284)	53	1	.64	+	1.56	4.75E-01
mRNA metabolic process (GO:0016071)	159	3	1.92	+	1.56	4.44E-01
lipoprotein metabolic process (GO:0042157)	54	1	.65	+	1.53	4.82E-01
aromatic compound catabolic process (GO:0019439)	108	2	1.30	+	1.53	3.75E-01
regulation of phosphorylation (GO:0042325)	162	3	1.95	+	1.53	4.49E-01
muscle structure development (GO:0061061)	54	1	.65	+	1.53	4.82E-01
response to stress (GO:0006950)	435	8	5.25	+	1.52	2.55E-01
nucleoside phosphate metabolic process (GO:0006753)	109	2	1.32	+	1.52	3.80E-01
generation of precursor metabolites and energy (GO:0006091)	55	1	.66	+	1.51	4.88E-01
glycerophospholipid metabolic process (GO:0006650)	111	2	1.34	+	1.49	3.88E-01
cellular catabolic process (GO:0044248)	278	5	3.35	+	1.49	3.92E-01
intracellular transport (GO:0046907)	391	7	4.72	+	1.48	2.41E-01
regulation of RNA splicing (GO:0043484)	56	1	.68	+	1.48	4.94E-01
regulation of actin filament organization (GO:0110053)	56	1	.68	+	1.48	4.94E-01
regulation of RNA metabolic process (GO:0051252)	1124	20	13.56	+	1.47	8.17E-02
negative regulation of response to stimulus (GO:0048585)	169	3	2.04	+	1.47	4.61E-01
organic cyclic compound catabolic process (GO:1901361)	113	2	1.36	+	1.47	3.97E-01
Golgi vesicle transport (GO:0048193)	113	2	1.36	+	1.47	3.97E-01
amino acid transport (GO:0006865)	57	1	.69	+	1.45	5.00E-01
regulation of transcription by RNA polymerase II (GO:0006357)	866	15	10.45	+	1.44	1.44E-01
calcium ion transmembrane transport (GO:0070588)	58	1	.70	+	1.43	5.06E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219)	1161	20	14.01	+	1.43	8.94E-02
positive regulation of molecular function (GO:0044093)	175	3	2.11	+	1.42	4.71E-01
regulation of phosphorus metabolic process (GO:0051174)	176	3	2.12	+	1.41	4.73E-01
regulation of phosphate metabolic process (GO:0019220)	176	3	2.12	+	1.41	4.73E-01
translation (GO:0006412)	118	2	1.42	+	1.40	6.55E-01
regulation of vesicle-mediated transport (GO:0060627)	59	1	.71	+	1.40	5.12E-01
protein-containing complex organization (GO:0043933)	295	5	3.56	+	1.40	4.09E-01
localization (GO:0051179)	1363	23	16.44	+	1.40	8.56E-02
organic anion transport (GO:0015711)	119	2	1.44	+	1.39	6.56E-01
gene expression (GO:0010467)	658	11	7.94	+	1.39	2.66E-01
macromolecule biosynthetic process (GO:0009059)	838	14	10.11	+	1.38	1.89E-01
regulation of DNA-templated transcription (GO:0006355)	1018	17	12.28	+	1.38	1.73E-01
regulation of RNA biosynthetic process (GO:2001141)	1018	17	12.28	+	1.38	1.73E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	60	1	.72	+	1.38	5.18E-01
synapse organization (GO:0050808)	60	1	.72	+	1.38	5.18E-01
peptide biosynthetic process (GO:0043043)	121	2	1.46	+	1.37	6.59E-01
cellular biosynthetic process (GO:0044249)	1094	18	13.20	+	1.36	1.87E-01
embryo development (GO:0009790)	61	1	.74	+	1.36	5.24E-01
establishment of protein localization (GO:0045184)	246	4	2.97	+	1.35	5.44E-01
regulation of gene expression (GO:0010468)	1304	21	15.73	+	1.33	1.75E-01
organic substance biosynthetic process (GO:1901576)	1120	18	13.51	+	1.33	1.94E-01
biosynthetic process (GO:0009058)	1123	18	13.55	+	1.33	1.95E-01
purine ribonucleotide metabolic process (GO:0009150)	63	1	.76	+	1.32	5.35E-01
regulation of macromolecule biosynthetic process (GO:0010556)	1324	21	15.97	+	1.31	1.80E-01
regulation of cellular biosynthetic process (GO:0031326)	1332	21	16.07	+	1.31	1.82E-01
glycerolipid metabolic process (GO:0046486)	127	2	1.53	+	1.31	6.67E-01
regulation of catabolic process (GO:0009894)	127	2	1.53	+	1.31	6.67E-01
regulation of biosynthetic process (GO:0009889)	1337	21	16.13	+	1.30	1.84E-01
positive regulation of multicellular organismal process (GO:0051240)	64	1	.77	+	1.30	5.41E-01
organophosphate metabolic process (GO:0019637)	256	4	3.09	+	1.30	5.54E-01
macromolecule localization (GO:0033036)	513	8	6.19	+	1.29	4.07E-01
transport (GO:0006810)	1158	18	13.97	+	1.29	2.54E-01
regulation of cellular metabolic process (GO:0031323)	1547	24	18.66	+	1.29	2.08E-01
proteasomal protein catabolic process (GO:0010498)	129	2	1.56	+	1.29	6.70E-01
nitrogen compound transport (GO:0071705)	323	5	3.90	+	1.28	5.98E-01
enzyme-linked receptor protein signaling pathway (GO:0007167)	194	3	2.34	+	1.28	5.09E-01
negative regulation of cellular metabolic process (GO:0031324)	324	5	3.91	+	1.28	5.99E-01
regulation of supramolecular fiber organization (GO:1902903)	65	1	.78	+	1.28	5.47E-01
response to external stimulus (GO:0009605)	131	2	1.58	+	1.27	6.73E-01
carbohydrate derivative biosynthetic process (GO:1901137)	197	3	2.38	+	1.26	5.15E-01
regulation of localization (GO:0032879)	198	3	2.39	+	1.26	5.17E-01
sulfur compound metabolic process (GO:0006790)	67	1	.81	+	1.24	5.58E-01
phospholipid metabolic process (GO:0006644)	135	2	1.63	+	1.23	6.79E-01
establishment of localization (GO:0051234)	1220	18	14.72	+	1.22	3.33E-01
negative regulation of macromolecule metabolic process (GO:0010605)	339	5	4.09	+	1.22	6.08E-01
ncRNA metabolic process (GO:0034660)	204	3	2.46	+	1.22	7.39E-01
cellular metabolic process (GO:0044237)	1983	29	23.92	+	1.21	2.57E-01
regulation of metabolic process (GO:0019222)	1643	24	19.82	+	1.21	3.27E-01
multicellular organism development (GO:0007275)	622	9	7.50	+	1.20	5.68E-01
positive regulation of cellular metabolic process (GO:0031325)	416	6	5.02	+	1.20	6.43E-01
anatomical structure development (GO:0048856)	834	12	10.06	+	1.19	5.08E-01
negative regulation of DNA-templated transcription (GO:0045892)	140	2	1.69	+	1.18	6.87E-01
negative regulation of RNA biosynthetic process (GO:1902679)	140	2	1.69	+	1.18	6.87E-01
calcium ion transport (GO:0006816)	70	1	.84	+	1.18	5.74E-01
negative regulation of metabolic process (GO:0009892)	351	5	4.23	+	1.18	6.17E-01
negative regulation of biological process (GO:0048519)	706	10	8.52	+	1.17	5.91E-01
regulation of nitrogen compound metabolic process (GO:0051171)	1419	20	17.12	+	1.17	4.35E-01
protein polyubiquitination (GO:0000209)	71	1	.86	+	1.17	5.79E-01
intracellular signaling cassette (GO:0141124)	143	2	1.73	+	1.16	6.92E-01
organic substance transport (GO:0071702)	429	6	5.18	+	1.16	6.50E-01
cell development (GO:0048468)	287	4	3.46	+	1.16	7.80E-01
regulation of primary metabolic process (GO:0080090)	1437	20	17.34	+	1.15	5.17E-01
peptidyl-serine phosphorylation (GO:0018105)	72	1	.87	+	1.15	5.84E-01
peptidyl-serine modification (GO:0018209)	72	1	.87	+	1.15	5.84E-01
nucleobase-containing compound metabolic process (GO:0006139)	799	11	9.64	+	1.14	6.13E-01
organonitrogen compound biosynthetic process (GO:1901566)	439	6	5.30	+	1.13	6.56E-01
regulation of macromolecule metabolic process (GO:0060255)	1540	21	18.58	+	1.13	5.30E-01
RNA metabolic process (GO:0016070)	441	6	5.32	+	1.13	6.57E-01
small molecule metabolic process (GO:0044281)	370	5	4.46	+	1.12	8.06E-01
amide biosynthetic process (GO:0043604)	148	2	1.79	+	1.12	7.00E-01
macromolecule catabolic process (GO:0009057)	297	4	3.58	+	1.12	7.84E-01
regulation of mitotic cell cycle (GO:0007346)	75	1	.90	+	1.11	5.99E-01
metabolic process (GO:0008152)	2568	34	30.98	+	1.10	5.37E-01
positive regulation of cellular process (GO:0048522)	759	10	9.16	+	1.09	7.30E-01
regulation of actin cytoskeleton organization (GO:0032956)	76	1	.92	+	1.09	6.04E-01
heterocycle metabolic process (GO:0046483)	839	11	10.12	+	1.09	7.42E-01
positive regulation of biological process (GO:0048518)	843	11	10.17	+	1.08	7.42E-01
catabolic process (GO:0009056)	537	7	6.48	+	1.08	8.38E-01
cellular aromatic compound metabolic process (GO:0006725)	847	11	10.22	+	1.08	7.43E-01
regulation of actin filament-based process (GO:0032970)	77	1	.93	+	1.08	6.09E-01
intracellular signal transduction (GO:0035556)	308	4	3.72	+	1.08	7.89E-01
exocytosis (GO:0006887)	77	1	.93	+	1.08	6.09E-01
positive regulation of metabolic process (GO:0009893)	463	6	5.59	+	1.07	8.26E-01
transmembrane transport (GO:0055085)	388	5	4.68	+	1.07	8.11E-01
positive regulation of RNA metabolic process (GO:0051254)	233	3	2.81	+	1.07	7.61E-01
response to stimulus (GO:0050896)	1476	19	17.81	+	1.07	7.03E-01
regulation of cellular process (GO:0050794)	3115	40	37.58	+	1.06	6.30E-01
negative regulation of RNA metabolic process (GO:0051253)	156	2	1.88	+	1.06	7.13E-01
developmental process (GO:0032502)	937	12	11.30	+	1.06	7.55E-01
cellular process (GO:0009987)	5330	68	64.30	+	1.06	5.46E-01
lipid biosynthetic process (GO:0008610)	157	2	1.89	+	1.06	7.15E-01
biological regulation (GO:0065007)	3485	44	42.04	+	1.05	7.10E-01
peptide metabolic process (GO:0006518)	159	2	1.92	+	1.04	7.18E-01
cellular nitrogen compound metabolic process (GO:0034641)	959	12	11.57	+	1.04	8.77E-01
nucleobase-containing compound biosynthetic process (GO:0034654)	160	2	1.93	+	1.04	7.20E-01
biological_process (GO:0008150)	7305	91	88.13	+	1.03	6.52E-01
regulation of biological process (GO:0050789)	3297	41	39.78	+	1.03	8.50E-01
organic cyclic compound metabolic process (GO:1901360)	885	11	10.68	+	1.03	8.72E-01
protein metabolic process (GO:0019538)	1208	15	14.57	+	1.03	8.89E-01
primary metabolic process (GO:0044238)	2343	29	28.27	+	1.03	8.32E-01
organelle assembly (GO:0070925)	243	3	2.93	+	1.02	7.69E-01
macromolecule metabolic process (GO:0043170)	1874	23	22.61	+	1.02	9.08E-01
organic substance metabolic process (GO:0071704)	2459	30	29.67	+	1.01	9.17E-01
cell surface receptor signaling pathway (GO:0007166)	410	5	4.95	+	1.01	8.20E-01
ncRNA processing (GO:0034470)	165	2	1.99	+	1.00	1.00E00
nucleic acid metabolic process (GO:0090304)	662	8	7.99	+	1.00	1.00E00
establishment of organelle localization (GO:0051656)	83	1	1.00	-	1.00	1.00E00
organonitrogen compound metabolic process (GO:1901564)	1511	18	18.23	-	.99	1.00E00
positive regulation of cellular component organization (GO:0051130)	84	1	1.01	-	.99	1.00E00
regulation of catalytic activity (GO:0050790)	252	3	3.04	-	.99	1.00E00
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	253	3	3.05	-	.98	1.00E00
cellular nitrogen compound biosynthetic process (GO:0044271)	338	4	4.08	-	.98	1.00E00
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	169	2	2.04	-	.98	1.00E00
purine nucleotide metabolic process (GO:0006163)	85	1	1.03	-	.98	1.00E00
phosphate-containing compound metabolic process (GO:0006796)	512	6	6.18	-	.97	1.00E00
cell communication (GO:0007154)	1201	14	14.49	-	.97	1.00E00
nitrogen compound metabolic process (GO:0006807)	2145	25	25.88	-	.97	9.13E-01
phosphorus metabolic process (GO:0006793)	515	6	6.21	-	.97	1.00E00
circulatory system development (GO:0072359)	86	1	1.04	-	.96	1.00E00
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	88	1	1.06	-	.94	1.00E00
proteolysis (GO:0006508)	352	4	4.25	-	.94	1.00E00
Unclassified (UNCLASSIFIED)	3968	45	47.87	-	.94	6.52E-01
heterocycle biosynthetic process (GO:0018130)	179	2	2.16	-	.93	1.00E00
neuron projection development (GO:0031175)	179	2	2.16	-	.93	1.00E00
mRNA splicing, via spliceosome (GO:0000398)	90	1	1.09	-	.92	1.00E00
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	90	1	1.09	-	.92	1.00E00
RNA splicing, via transesterification reactions (GO:0000375)	90	1	1.09	-	.92	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	181	2	2.18	-	.92	1.00E00
peptidyl-amino acid modification (GO:0018193)	181	2	2.18	-	.92	1.00E00
aromatic compound biosynthetic process (GO:0019438)	183	2	2.21	-	.91	1.00E00
animal organ development (GO:0048513)	277	3	3.34	-	.90	1.00E00
modification-dependent protein catabolic process (GO:0019941)	185	2	2.23	-	.90	1.00E00
cellular lipid metabolic process (GO:0044255)	278	3	3.35	-	.89	1.00E00
secretion by cell (GO:0032940)	93	1	1.12	-	.89	1.00E00
protein phosphorylation (GO:0006468)	188	2	2.27	-	.88	1.00E00
regulation of programmed cell death (GO:0043067)	94	1	1.13	-	.88	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	188	2	2.27	-	.88	1.00E00
cellular component organization or biogenesis (GO:0071840)	1600	17	19.30	-	.88	7.10E-01
cellular component organization (GO:0016043)	1506	16	18.17	-	.88	7.03E-01
negative regulation of cellular process (GO:0048523)	660	7	7.96	-	.88	8.55E-01
extracellular matrix organization (GO:0030198)	95	1	1.15	-	.87	1.00E00
extracellular structure organization (GO:0043062)	95	1	1.15	-	.87	1.00E00
external encapsulating structure organization (GO:0045229)	95	1	1.15	-	.87	1.00E00
secretion (GO:0046903)	95	1	1.15	-	.87	1.00E00
signal transduction (GO:0007165)	1058	11	12.76	-	.86	7.67E-01
cellular response to stimulus (GO:0051716)	1350	14	16.29	-	.86	6.89E-01
RNA processing (GO:0006396)	290	3	3.50	-	.86	1.00E00
cell junction organization (GO:0034330)	97	1	1.17	-	.85	1.00E00
neuron development (GO:0048666)	195	2	2.35	-	.85	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	293	3	3.53	-	.85	1.00E00
intracellular monoatomic cation homeostasis (GO:0030003)	98	1	1.18	-	.85	1.00E00
intracellular monoatomic ion homeostasis (GO:0006873)	98	1	1.18	-	.85	1.00E00
signaling (GO:0023052)	1177	12	14.20	-	.85	6.71E-01
RNA splicing (GO:0008380)	99	1	1.19	-	.84	1.00E00
amino acid metabolic process (GO:0006520)	99	1	1.19	-	.84	1.00E00
phosphorylation (GO:0016310)	200	2	2.41	-	.83	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	202	2	2.44	-	.82	1.00E00
plasma membrane bounded cell projection organization (GO:0120036)	305	3	3.68	-	.82	1.00E00
cell projection organization (GO:0030030)	311	3	3.75	-	.80	1.00E00
cilium assembly (GO:0060271)	104	1	1.25	-	.80	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	104	1	1.25	-	.80	1.00E00
regulation of cytoskeleton organization (GO:0051493)	105	1	1.27	-	.79	1.00E00
export from cell (GO:0140352)	105	1	1.27	-	.79	1.00E00
lipid metabolic process (GO:0006629)	316	3	3.81	-	.79	1.00E00
chromosome organization (GO:0051276)	106	1	1.28	-	.78	1.00E00
intracellular chemical homeostasis (GO:0055082)	108	1	1.30	-	.77	1.00E00
amide metabolic process (GO:0043603)	216	2	2.61	-	.77	1.00E00
regulation of molecular function (GO:0065009)	326	3	3.93	-	.76	1.00E00
cellular response to stress (GO:0033554)	327	3	3.95	-	.76	1.00E00
glycoprotein biosynthetic process (GO:0009101)	111	1	1.34	-	.75	1.00E00
mRNA processing (GO:0006397)	111	1	1.34	-	.75	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	112	1	1.35	-	.74	1.00E00
organelle localization (GO:0051640)	113	1	1.36	-	.73	1.00E00
G protein-coupled receptor signaling pathway (GO:0007186)	228	2	2.75	-	.73	1.00E00
organelle organization (GO:0006996)	912	8	11.00	-	.73	4.29E-01
regulation of cellular component biogenesis (GO:0044087)	114	1	1.38	-	.73	1.00E00
DNA metabolic process (GO:0006259)	230	2	2.77	-	.72	1.00E00
proteolysis involved in protein catabolic process (GO:0051603)	231	2	2.79	-	.72	1.00E00
monoatomic cation homeostasis (GO:0055080)	116	1	1.40	-	.71	1.00E00
organic substance catabolic process (GO:1901575)	471	4	5.68	-	.70	6.64E-01
ribosome biogenesis (GO:0042254)	118	1	1.42	-	.70	1.00E00
monoatomic ion homeostasis (GO:0050801)	119	1	1.44	-	.70	1.00E00
cilium organization (GO:0044782)	119	1	1.44	-	.70	1.00E00
cellular component biogenesis (GO:0044085)	597	5	7.20	-	.69	5.61E-01
protein catabolic process (GO:0030163)	241	2	2.91	-	.69	1.00E00
cell projection assembly (GO:0030031)	122	1	1.47	-	.68	1.00E00
chemical synaptic transmission (GO:0007268)	125	1	1.51	-	.66	1.00E00
anterograde trans-synaptic signaling (GO:0098916)	125	1	1.51	-	.66	1.00E00
cellular component assembly (GO:0022607)	501	4	6.04	-	.66	5.30E-01
trans-synaptic signaling (GO:0099537)	126	1	1.52	-	.66	1.00E00
negative regulation of nitrogen compound metabolic process (GO:0051172)	254	2	3.06	-	.65	7.72E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	383	3	4.62	-	.65	6.32E-01
glycoprotein metabolic process (GO:0009100)	128	1	1.54	-	.65	1.00E00
system development (GO:0048731)	513	4	6.19	-	.65	5.31E-01
neuron differentiation (GO:0030182)	259	2	3.12	-	.64	7.73E-01
cellular homeostasis (GO:0019725)	131	1	1.58	-	.63	1.00E00
macromolecule modification (GO:0043412)	798	6	9.63	-	.62	3.10E-01
tissue development (GO:0009888)	133	1	1.60	-	.62	1.00E00
positive regulation of macromolecule metabolic process (GO:0010604)	400	3	4.83	-	.62	6.36E-01
generation of neurons (GO:0048699)	270	2	3.26	-	.61	7.75E-01
synaptic signaling (GO:0099536)	135	1	1.63	-	.61	1.00E00
regulation of cell cycle (GO:0051726)	136	1	1.64	-	.61	1.00E00
neuron projection morphogenesis (GO:0048812)	139	1	1.68	-	.60	1.00E00
cell projection morphogenesis (GO:0048858)	140	1	1.69	-	.59	1.00E00
plasma membrane bounded cell projection morphogenesis (GO:0120039)	140	1	1.69	-	.59	1.00E00
cell differentiation (GO:0030154)	571	4	6.89	-	.58	3.26E-01
cellular developmental process (GO:0048869)	571	4	6.89	-	.58	3.26E-01
protein modification process (GO:0036211)	717	5	8.65	-	.58	2.85E-01
neurogenesis (GO:0022008)	289	2	3.49	-	.57	5.88E-01
cellular response to organic substance (GO:0071310)	149	1	1.80	-	.56	1.00E00
regulation of transport (GO:0051049)	154	1	1.86	-	.54	1.00E00
chemical homeostasis (GO:0048878)	154	1	1.86	-	.54	1.00E00
cell migration (GO:0016477)	157	1	1.89	-	.53	1.00E00
protein ubiquitination (GO:0016567)	158	1	1.91	-	.52	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	161	1	1.94	-	.51	1.00E00
cellular anatomical entity morphogenesis (GO:0032989)	162	1	1.95	-	.51	1.00E00
positive regulation of transcription by RNA polymerase II (GO:0045944)	167	1	2.01	-	.50	7.26E-01
cell morphogenesis (GO:0000902)	168	1	2.03	-	.49	7.26E-01
anatomical structure morphogenesis (GO:0009653)	338	2	4.08	-	.49	4.45E-01
regulation of response to stimulus (GO:0048583)	513	3	6.19	-	.48	2.95E-01
protein-containing complex assembly (GO:0065003)	172	1	2.08	-	.48	7.26E-01
organonitrogen compound catabolic process (GO:1901565)	346	2	4.17	-	.48	4.47E-01
regulation of organelle organization (GO:0033043)	177	1	2.14	-	.47	7.27E-01
cell motility (GO:0048870)	178	1	2.15	-	.47	7.27E-01
homeostatic process (GO:0042592)	181	1	2.18	-	.46	7.28E-01
protein modification by small protein conjugation (GO:0032446)	183	1	2.21	-	.45	7.29E-01
carboxylic acid metabolic process (GO:0019752)	189	1	2.28	-	.44	7.31E-01
organic acid metabolic process (GO:0006082)	191	1	2.30	-	.43	7.32E-01
oxoacid metabolic process (GO:0043436)	191	1	2.30	-	.43	7.32E-01
nervous system development (GO:0007399)	382	2	4.61	-	.43	3.34E-01
inorganic cation transmembrane transport (GO:0098662)	193	1	2.33	-	.43	7.33E-01
monoatomic cation transmembrane transport (GO:0098655)	193	1	2.33	-	.43	7.33E-01
DNA damage response (GO:0006974)	199	1	2.40	-	.42	7.36E-01
positive regulation of DNA-templated transcription (GO:0045893)	201	1	2.42	-	.41	5.23E-01
positive regulation of RNA biosynthetic process (GO:1902680)	201	1	2.42	-	.41	5.23E-01
actin cytoskeleton organization (GO:0030036)	202	1	2.44	-	.41	5.23E-01
actin filament-based process (GO:0030029)	207	1	2.50	-	.40	5.23E-01
cellular response to chemical stimulus (GO:0070887)	209	1	2.52	-	.40	5.24E-01
response to organic substance (GO:0010033)	218	1	2.63	-	.38	5.26E-01
cell-cell signaling (GO:0007267)	221	1	2.67	-	.38	5.27E-01
metal ion transport (GO:0030001)	221	1	2.67	-	.38	5.27E-01
inorganic ion transmembrane transport (GO:0098660)	223	1	2.69	-	.37	5.28E-01
monoatomic cation transport (GO:0006812)	236	1	2.85	-	.35	5.36E-01
monoatomic ion transmembrane transport (GO:0034220)	239	1	2.88	-	.35	3.75E-01
protein modification by small protein conjugation or removal (GO:0070647)	246	1	2.97	-	.34	3.75E-01
post-translational protein modification (GO:0043687)	260	1	3.14	-	.32	3.80E-01
positive regulation of macromolecule biosynthetic process (GO:0010557)	264	1	3.18	-	.31	3.82E-01
positive regulation of cellular biosynthetic process (GO:0031328)	269	1	3.25	-	.31	3.85E-01
regulation of cellular component organization (GO:0051128)	270	1	3.26	-	.31	3.86E-01
positive regulation of biosynthetic process (GO:0009891)	270	1	3.26	-	.31	3.86E-01
monoatomic ion transport (GO:0006811)	286	1	3.45	-	.29	2.68E-01
response to chemical (GO:0042221)	290	1	3.50	-	.29	2.69E-01
cytoskeleton organization (GO:0007010)	389	1	4.69	-	.21	9.42E-02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	2	0	.02	-	 < 0.01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	21	0	.25	-	 < 0.01	1.00E00
mononuclear cell migration (GO:0071674)	3	0	.04	-	 < 0.01	1.00E00
intermediate filament organization (GO:0045109)	9	0	.11	-	 < 0.01	1.00E00
tissue morphogenesis (GO:0048729)	21	0	.25	-	 < 0.01	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	30	0	.36	-	 < 0.01	1.00E00
centriole assembly (GO:0098534)	9	0	.11	-	 < 0.01	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	13	0	.16	-	 < 0.01	1.00E00
intermediate filament-based process (GO:0045103)	13	0	.16	-	 < 0.01	1.00E00
vitamin transport (GO:0051180)	9	0	.11	-	 < 0.01	1.00E00
TOR signaling (GO:0031929)	9	0	.11	-	 < 0.01	1.00E00
protein localization to mitochondrion (GO:0070585)	20	0	.24	-	 < 0.01	1.00E00
mitotic cytokinesis (GO:0000281)	12	0	.14	-	 < 0.01	1.00E00
nuclear division (GO:0000280)	67	0	.81	-	 < 0.01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	22	0	.27	-	 < 0.01	1.00E00
sperm-egg recognition (GO:0035036)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	18	0	.22	-	 < 0.01	1.00E00
regulation of actin filament depolymerization (GO:0030834)	20	0	.24	-	 < 0.01	1.00E00
regulation of actin filament polymerization (GO:0030833)	40	0	.48	-	 < 0.01	1.00E00
regulation of actin filament length (GO:0030832)	43	0	.52	-	 < 0.01	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	2	0	.02	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	17	0	.21	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	15	0	.18	-	 < 0.01	1.00E00
mitotic cell cycle (GO:0000278)	156	0	1.88	-	 < 0.01	2.68E-01
supramolecular fiber organization (GO:0097435)	194	0	2.34	-	 < 0.01	1.79E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	15	0	.18	-	 < 0.01	1.00E00
lymphocyte mediated immunity (GO:0002449)	2	0	.02	-	 < 0.01	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	21	0	.25	-	 < 0.01	1.00E00
leukocyte mediated immunity (GO:0002443)	2	0	.02	-	 < 0.01	1.00E00
apoptotic cell clearance (GO:0043277)	4	0	.05	-	 < 0.01	1.00E00
nuclear export (GO:0051168)	47	0	.57	-	 < 0.01	1.00E00
oligodendrocyte differentiation (GO:0048709)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of monoatomic ion transport (GO:0043271)	16	0	.19	-	 < 0.01	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	7	0	.08	-	 < 0.01	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	51	0	.62	-	 < 0.01	1.00E00
endothelial cell differentiation (GO:0045446)	4	0	.05	-	 < 0.01	1.00E00
neutrophil migration (GO:1990266)	3	0	.04	-	 < 0.01	1.00E00
fat cell differentiation (GO:0045444)	2	0	.02	-	 < 0.01	1.00E00
programmed cell death (GO:0012501)	58	0	.70	-	 < 0.01	1.00E00
axo-dendritic transport (GO:0008088)	16	0	.19	-	 < 0.01	1.00E00
regulation of establishment of protein localization (GO:0070201)	13	0	.16	-	 < 0.01	1.00E00
mitochondrial fission (GO:0000266)	8	0	.10	-	 < 0.01	1.00E00
regulation of monoatomic ion transport (GO:0043269)	64	0	.77	-	 < 0.01	1.00E00
positive regulation of hormone secretion (GO:0046887)	1	0	.01	-	 < 0.01	1.00E00
regulation of potassium ion transport (GO:0043266)	15	0	.18	-	 < 0.01	1.00E00
membrane invagination (GO:0010324)	9	0	.11	-	 < 0.01	1.00E00
regulation of peptide secretion (GO:0002791)	3	0	.04	-	 < 0.01	1.00E00
peptide secretion (GO:0002790)	3	0	.04	-	 < 0.01	1.00E00
regulation of hormone secretion (GO:0046883)	5	0	.06	-	 < 0.01	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	13	0	.16	-	 < 0.01	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	8	0	.10	-	 < 0.01	1.00E00
nucleotide catabolic process (GO:0009166)	23	0	.28	-	 < 0.01	1.00E00
regulation of cell projection assembly (GO:0060491)	22	0	.27	-	 < 0.01	1.00E00
nucleoside catabolic process (GO:0009164)	8	0	.10	-	 < 0.01	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	14	0	.17	-	 < 0.01	1.00E00
negative regulation of protein catabolic process (GO:0042177)	11	0	.13	-	 < 0.01	1.00E00
regulation of protein catabolic process (GO:0042176)	41	0	.49	-	 < 0.01	1.00E00
response to interleukin-1 (GO:0070555)	2	0	.02	-	 < 0.01	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	24	0	.29	-	 < 0.01	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	29	0	.35	-	 < 0.01	1.00E00
actin filament bundle organization (GO:0061572)	19	0	.23	-	 < 0.01	1.00E00
hormone secretion (GO:0046879)	3	0	.04	-	 < 0.01	1.00E00
ceramide biosynthetic process (GO:0046513)	22	0	.27	-	 < 0.01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	52	0	.63	-	 < 0.01	1.00E00
striated muscle cell differentiation (GO:0051146)	30	0	.36	-	 < 0.01	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	16	0	.19	-	 < 0.01	1.00E00
heme metabolic process (GO:0042168)	8	0	.10	-	 < 0.01	1.00E00
positive regulation of cell cycle (GO:0045787)	23	0	.28	-	 < 0.01	1.00E00
negative regulation of cell cycle (GO:0045786)	56	0	.68	-	 < 0.01	1.00E00
response to fatty acid (GO:0070542)	1	0	.01	-	 < 0.01	1.00E00
spliceosomal complex assembly (GO:0000245)	18	0	.22	-	 < 0.01	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	41	0	.49	-	 < 0.01	1.00E00
regulation of lipid metabolic process (GO:0019216)	11	0	.13	-	 < 0.01	1.00E00
axon development (GO:0061564)	129	0	1.56	-	 < 0.01	4.11E-01
respiratory electron transport chain (GO:0022904)	11	0	.13	-	 < 0.01	1.00E00
protein hydroxylation (GO:0018126)	14	0	.17	-	 < 0.01	1.00E00
electron transport chain (GO:0022900)	14	0	.17	-	 < 0.01	1.00E00
glycerolipid catabolic process (GO:0046503)	14	0	.17	-	 < 0.01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	33	0	.40	-	 < 0.01	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	25	0	.30	-	 < 0.01	1.00E00
multivesicular body sorting pathway (GO:0071985)	21	0	.25	-	 < 0.01	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	1	0	.01	-	 < 0.01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	18	0	.22	-	 < 0.01	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	31	0	.37	-	 < 0.01	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	6	0	.07	-	 < 0.01	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	2	0	.02	-	 < 0.01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	28	0	.34	-	 < 0.01	1.00E00
regulation of stress fiber assembly (GO:0051492)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of blood pressure (GO:0045776)	6	0	.07	-	 < 0.01	1.00E00
protein K63-linked deubiquitination (GO:0070536)	7	0	.08	-	 < 0.01	1.00E00
protein K63-linked ubiquitination (GO:0070534)	4	0	.05	-	 < 0.01	1.00E00
mitochondrial fusion (GO:0008053)	9	0	.11	-	 < 0.01	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	30	0	.36	-	 < 0.01	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	6	0	.07	-	 < 0.01	1.00E00
immune response-regulating signaling pathway (GO:0002764)	36	0	.43	-	 < 0.01	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	24	0	.29	-	 < 0.01	1.00E00
negative regulation of cellular component organization (GO:0051129)	61	0	.74	-	 < 0.01	1.00E00
regulation of filopodium assembly (GO:0051489)	6	0	.07	-	 < 0.01	1.00E00
intracellular glucose homeostasis (GO:0001678)	5	0	.06	-	 < 0.01	1.00E00
regulation of bone remodeling (GO:0046850)	3	0	.04	-	 < 0.01	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	20	0	.24	-	 < 0.01	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	6	0	.07	-	 < 0.01	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	10	0	.12	-	 < 0.01	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	23	0	.28	-	 < 0.01	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	31	0	.37	-	 < 0.01	1.00E00
regulation of angiogenesis (GO:0045765)	21	0	.25	-	 < 0.01	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	17	0	.21	-	 < 0.01	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of adenylate cyclase activity (GO:0045762)	5	0	.06	-	 < 0.01	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	7	0	.08	-	 < 0.01	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	13	0	.16	-	 < 0.01	1.00E00
microtubule cytoskeleton organization (GO:0000226)	154	0	1.86	-	 < 0.01	2.68E-01
motor neuron axon guidance (GO:0008045)	6	0	.07	-	 < 0.01	1.00E00
positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	15	0	.18	-	 < 0.01	1.00E00
negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	5	0	.06	-	 < 0.01	1.00E00
regulation of proteolysis involved in protein catabolic process (GO:1903050)	29	0	.35	-	 < 0.01	1.00E00
innate immune response-activating signaling pathway (GO:0002758)	11	0	.13	-	 < 0.01	1.00E00
immune response-activating signaling pathway (GO:0002757)	35	0	.42	-	 < 0.01	1.00E00
peptidyl-tyrosine phosphorylation (GO:0018108)	5	0	.06	-	 < 0.01	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	17	0	.21	-	 < 0.01	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	14	0	.17	-	 < 0.01	1.00E00
negative regulation of cell communication (GO:0010648)	154	0	1.86	-	 < 0.01	2.68E-01
filopodium assembly (GO:0046847)	3	0	.04	-	 < 0.01	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of cell communication (GO:0010647)	183	0	2.21	-	 < 0.01	1.77E-01
skin development (GO:0043588)	3	0	.04	-	 < 0.01	1.00E00
regulation of cell communication (GO:0010646)	501	0	6.04	-	 < 0.01	4.86E-03
purine nucleoside monophosphate metabolic process (GO:0009126)	13	0	.16	-	 < 0.01	1.00E00
ear development (GO:0043583)	2	0	.02	-	 < 0.01	1.00E00
regulation of amide metabolic process (GO:0034248)	48	0	.58	-	 < 0.01	1.00E00
response to hypoxia (GO:0001666)	16	0	.19	-	 < 0.01	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	16	0	.19	-	 < 0.01	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	3	0	.04	-	 < 0.01	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	8	0	.10	-	 < 0.01	1.00E00
cell recognition (GO:0008037)	14	0	.17	-	 < 0.01	1.00E00
potassium ion import across plasma membrane (GO:1990573)	29	0	.35	-	 < 0.01	1.00E00
mitotic cell cycle process (GO:1903047)	123	0	1.48	-	 < 0.01	4.08E-01
negative regulation of T cell proliferation (GO:0042130)	2	0	.02	-	 < 0.01	1.00E00
meiotic cell cycle process (GO:1903046)	41	0	.49	-	 < 0.01	1.00E00
V(D)J recombination (GO:0033151)	2	0	.02	-	 < 0.01	1.00E00
hippo signaling (GO:0035329)	15	0	.18	-	 < 0.01	1.00E00
phospholipid dephosphorylation (GO:0046839)	31	0	.37	-	 < 0.01	1.00E00
negative regulation of organelle organization (GO:0010639)	50	0	.60	-	 < 0.01	1.00E00
carbohydrate phosphorylation (GO:0046835)	5	0	.06	-	 < 0.01	1.00E00
nucleoside metabolic process (GO:0009116)	14	0	.17	-	 < 0.01	1.00E00
cellular response to oxidative stress (GO:0034599)	9	0	.11	-	 < 0.01	1.00E00
regulation of T cell proliferation (GO:0042129)	3	0	.04	-	 < 0.01	1.00E00
eye development (GO:0001654)	28	0	.34	-	 < 0.01	1.00E00
calcium ion import (GO:0070509)	11	0	.13	-	 < 0.01	1.00E00
regulation of cell population proliferation (GO:0042127)	88	0	1.06	-	 < 0.01	6.29E-01
cytochrome complex assembly (GO:0017004)	2	0	.02	-	 < 0.01	1.00E00
nuclear chromosome segregation (GO:0098813)	50	0	.60	-	 < 0.01	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	3	0	.04	-	 < 0.01	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	28	0	.34	-	 < 0.01	1.00E00
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	4	0	.05	-	 < 0.01	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	6	0	.07	-	 < 0.01	1.00E00
sperm motility (GO:0097722)	1	0	.01	-	 < 0.01	1.00E00
regulation of endopeptidase activity (GO:0052548)	41	0	.49	-	 < 0.01	1.00E00
regulation of peptidase activity (GO:0052547)	42	0	.51	-	 < 0.01	1.00E00
positive regulation of gene expression (GO:0010628)	64	0	.77	-	 < 0.01	1.00E00
response to external biotic stimulus (GO:0043207)	39	0	.47	-	 < 0.01	1.00E00
oligopeptide transmembrane transport (GO:0035672)	2	0	.02	-	 < 0.01	1.00E00
osteoblast differentiation (GO:0001649)	5	0	.06	-	 < 0.01	1.00E00
neutrophil activation (GO:0042119)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of DNA repair (GO:0045739)	9	0	.11	-	 < 0.01	1.00E00
piRNA processing (GO:0034587)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of DNA repair (GO:0045738)	5	0	.06	-	 < 0.01	1.00E00
macrophage activation (GO:0042116)	1	0	.01	-	 < 0.01	1.00E00
odontogenesis (GO:0042476)	2	0	.02	-	 < 0.01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	2	0	.02	-	 < 0.01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	22	0	.27	-	 < 0.01	1.00E00
regulation of heart contraction (GO:0008016)	16	0	.19	-	 < 0.01	1.00E00
blood circulation (GO:0008015)	35	0	.42	-	 < 0.01	1.00E00
T cell activation (GO:0042110)	7	0	.08	-	 < 0.01	1.00E00
inner ear morphogenesis (GO:0042472)	2	0	.02	-	 < 0.01	1.00E00
chromosome localization (GO:0050000)	13	0	.16	-	 < 0.01	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.01	-	 < 0.01	1.00E00
protein localization to cilium (GO:0061512)	13	0	.16	-	 < 0.01	1.00E00
centriole elongation (GO:0061511)	1	0	.01	-	 < 0.01	1.00E00
antigen processing and presentation (GO:0019882)	3	0	.04	-	 < 0.01	1.00E00
sperm axoneme assembly (GO:0007288)	1	0	.01	-	 < 0.01	1.00E00
cardiolipin biosynthetic process (GO:0032049)	2	0	.02	-	 < 0.01	1.00E00
epithelium development (GO:0060429)	33	0	.40	-	 < 0.01	1.00E00
spermatid development (GO:0007286)	4	0	.05	-	 < 0.01	1.00E00
regulation of dephosphorylation (GO:0035303)	8	0	.10	-	 < 0.01	1.00E00
spermatogenesis (GO:0007283)	16	0	.19	-	 < 0.01	1.00E00
germ cell development (GO:0007281)	16	0	.19	-	 < 0.01	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	4	0	.05	-	 < 0.01	1.00E00
regulation of neuron projection development (GO:0010975)	36	0	.43	-	 < 0.01	1.00E00
carbohydrate transmembrane transport (GO:0034219)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	13	0	.16	-	 < 0.01	1.00E00
regulation of meiotic cell cycle (GO:0051445)	10	0	.12	-	 < 0.01	1.00E00
transport along microtubule (GO:0010970)	50	0	.60	-	 < 0.01	1.00E00
purine nucleotide catabolic process (GO:0006195)	17	0	.21	-	 < 0.01	1.00E00
positive regulation of translation (GO:0045727)	17	0	.21	-	 < 0.01	1.00E00
signal release (GO:0023061)	37	0	.45	-	 < 0.01	1.00E00
RNA modification (GO:0009451)	74	0	.89	-	 < 0.01	1.00E00
response to growth factor (GO:0070848)	75	0	.90	-	 < 0.01	1.00E00
positive regulation of T cell proliferation (GO:0042102)	2	0	.02	-	 < 0.01	1.00E00
mitochondrial transmembrane transport (GO:1990542)	36	0	.43	-	 < 0.01	1.00E00
eye photoreceptor cell development (GO:0042462)	1	0	.01	-	 < 0.01	1.00E00
regulation of cell size (GO:0008361)	12	0	.14	-	 < 0.01	1.00E00
regulation of cell shape (GO:0008360)	26	0	.31	-	 < 0.01	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	2	0	.02	-	 < 0.01	1.00E00
gamete generation (GO:0007276)	26	0	.31	-	 < 0.01	1.00E00
neuromuscular synaptic transmission (GO:0007274)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of GTPase activity (GO:0043547)	46	0	.55	-	 < 0.01	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	14	0	.17	-	 < 0.01	1.00E00
negative regulation of signaling (GO:0023057)	154	0	1.86	-	 < 0.01	2.68E-01
DNA geometric change (GO:0032392)	12	0	.14	-	 < 0.01	1.00E00
protein acylation (GO:0043543)	27	0	.33	-	 < 0.01	1.00E00
positive regulation of signaling (GO:0023056)	183	0	2.21	-	 < 0.01	1.77E-01
endothelial cell migration (GO:0043542)	4	0	.05	-	 < 0.01	1.00E00
IMP biosynthetic process (GO:0006188)	6	0	.07	-	 < 0.01	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	32	0	.39	-	 < 0.01	1.00E00
negative regulation of canonical Wnt signaling pathway (GO:0090090)	15	0	.18	-	 < 0.01	1.00E00
lipid translocation (GO:0034204)	22	0	.27	-	 < 0.01	1.00E00
regulation of signaling (GO:0023051)	505	0	6.09	-	 < 0.01	3.00E-03
cGMP biosynthetic process (GO:0006182)	3	0	.04	-	 < 0.01	1.00E00
response to organic cyclic compound (GO:0014070)	27	0	.33	-	 < 0.01	1.00E00
neurotransmitter secretion (GO:0007269)	32	0	.39	-	 < 0.01	1.00E00
negative regulation of macroautophagy (GO:0016242)	4	0	.05	-	 < 0.01	1.00E00
regulation of macroautophagy (GO:0016241)	15	0	.18	-	 < 0.01	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	4	0	.05	-	 < 0.01	1.00E00
Rho protein signal transduction (GO:0007266)	21	0	.25	-	 < 0.01	1.00E00
Ras protein signal transduction (GO:0007265)	25	0	.30	-	 < 0.01	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	6	0	.07	-	 < 0.01	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	4	0	.05	-	 < 0.01	1.00E00
small GTPase-mediated signal transduction (GO:0007264)	58	0	.70	-	 < 0.01	1.00E00
regulation of metal ion transport (GO:0010959)	48	0	.58	-	 < 0.01	1.00E00
regulation of chromatin organization (GO:1902275)	4	0	.05	-	 < 0.01	1.00E00
regulation of peptide transport (GO:0090087)	3	0	.04	-	 < 0.01	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of peptidase activity (GO:0010952)	20	0	.24	-	 < 0.01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	22	0	.27	-	 < 0.01	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	19	0	.23	-	 < 0.01	1.00E00
negative regulation of nuclear division (GO:0051784)	13	0	.16	-	 < 0.01	1.00E00
replication fork processing (GO:0031297)	14	0	.17	-	 < 0.01	1.00E00
regulation of nuclear division (GO:0051783)	25	0	.30	-	 < 0.01	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	11	0	.13	-	 < 0.01	1.00E00
hormone biosynthetic process (GO:0042446)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of cell division (GO:0051781)	2	0	.02	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of macroautophagy (GO:0016239)	10	0	.12	-	 < 0.01	1.00E00
pigment metabolic process (GO:0042440)	13	0	.16	-	 < 0.01	1.00E00
microautophagy (GO:0016237)	16	0	.19	-	 < 0.01	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	1	0	.01	-	 < 0.01	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	5	0	.06	-	 < 0.01	1.00E00
JNK cascade (GO:0007254)	6	0	.07	-	 < 0.01	1.00E00
negative regulation of cell cycle process (GO:0010948)	47	0	.57	-	 < 0.01	1.00E00
positive regulation of protein serine/threonine kinase activity (GO:0071902)	12	0	.14	-	 < 0.01	1.00E00
regulation of protein serine/threonine kinase activity (GO:0071900)	49	0	.59	-	 < 0.01	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of cyclase activity (GO:0031281)	9	0	.11	-	 < 0.01	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	19	0	.23	-	 < 0.01	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of cyclase activity (GO:0031280)	2	0	.02	-	 < 0.01	1.00E00
collagen fibril organization (GO:0030199)	9	0	.11	-	 < 0.01	1.00E00
endosome to lysosome transport (GO:0008333)	14	0	.17	-	 < 0.01	1.00E00
iron-sulfur cluster assembly (GO:0016226)	8	0	.10	-	 < 0.01	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	5	0	.06	-	 < 0.01	1.00E00
canonical NF-kappaB signal transduction (GO:0007249)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of TOR signaling (GO:0032008)	15	0	.18	-	 < 0.01	1.00E00
negative regulation of TOR signaling (GO:0032007)	10	0	.12	-	 < 0.01	1.00E00
non-motile cilium assembly (GO:1905515)	14	0	.17	-	 < 0.01	1.00E00
regulation of TOR signaling (GO:0032006)	28	0	.34	-	 < 0.01	1.00E00
intracellular sterol transport (GO:0032366)	3	0	.04	-	 < 0.01	1.00E00
intracellular lipid transport (GO:0032365)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of cell cycle process (GO:0090068)	22	0	.27	-	 < 0.01	1.00E00
regulation of anatomical structure size (GO:0090066)	63	0	.76	-	 < 0.01	1.00E00
response to light stimulus (GO:0009416)	24	0	.29	-	 < 0.01	1.00E00
regulation of cyclase activity (GO:0031279)	12	0	.14	-	 < 0.01	1.00E00
neuron apoptotic process (GO:0051402)	4	0	.05	-	 < 0.01	1.00E00
response to UV (GO:0009411)	7	0	.08	-	 < 0.01	1.00E00
purine nucleoside catabolic process (GO:0006152)	3	0	.04	-	 < 0.01	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of epithelial cell proliferation (GO:0050679)	7	0	.08	-	 < 0.01	1.00E00
protein deubiquitination (GO:0016579)	55	0	.66	-	 < 0.01	1.00E00
tRNA 3'-end processing (GO:0042780)	1	0	.01	-	 < 0.01	1.00E00
epithelial cell proliferation (GO:0050673)	1	0	.01	-	 < 0.01	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	5	0	.06	-	 < 0.01	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	22	0	.27	-	 < 0.01	1.00E00
developmental pigmentation (GO:0048066)	6	0	.07	-	 < 0.01	1.00E00
response to cold (GO:0009409)	1	0	.01	-	 < 0.01	1.00E00
response to heat (GO:0009408)	11	0	.13	-	 < 0.01	1.00E00
regulation of phosphatase activity (GO:0010921)	5	0	.06	-	 < 0.01	1.00E00
vasculature development (GO:0001944)	36	0	.43	-	 < 0.01	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	6	0	.07	-	 < 0.01	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	6	0	.07	-	 < 0.01	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	28	0	.34	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of Wnt signaling pathway (GO:0030177)	22	0	.27	-	 < 0.01	1.00E00
signal transduction in response to DNA damage (GO:0042770)	20	0	.24	-	 < 0.01	1.00E00
integrin-mediated signaling pathway (GO:0007229)	23	0	.28	-	 < 0.01	1.00E00
digestion (GO:0007586)	1	0	.01	-	 < 0.01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	26	0	.31	-	 < 0.01	1.00E00
response to topologically incorrect protein (GO:0035966)	26	0	.31	-	 < 0.01	1.00E00
hormone-mediated signaling pathway (GO:0009755)	22	0	.27	-	 < 0.01	1.00E00
endothelial cell proliferation (GO:0001935)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of protein phosphorylation (GO:0001934)	66	0	.80	-	 < 0.01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	32	0	.39	-	 < 0.01	1.00E00
regulation of protein phosphorylation (GO:0001932)	121	0	1.46	-	 < 0.01	4.08E-01
protein O-linked glycosylation (GO:0006493)	39	0	.47	-	 < 0.01	1.00E00
RNA transport (GO:0050658)	35	0	.42	-	 < 0.01	1.00E00
nucleic acid transport (GO:0050657)	35	0	.42	-	 < 0.01	1.00E00
protein import into peroxisome matrix (GO:0016558)	11	0	.13	-	 < 0.01	1.00E00
isoprenoid catabolic process (GO:0008300)	4	0	.05	-	 < 0.01	1.00E00
mRNA modification (GO:0016556)	8	0	.10	-	 < 0.01	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	10	0	.12	-	 < 0.01	1.00E00
Notch signaling pathway (GO:0007219)	22	0	.27	-	 < 0.01	1.00E00
regulation of proteolysis (GO:0030162)	73	0	.88	-	 < 0.01	1.00E00
glutamate receptor signaling pathway (GO:0007215)	9	0	.11	-	 < 0.01	1.00E00
dopamine receptor signaling pathway (GO:0007212)	6	0	.07	-	 < 0.01	1.00E00
response to glucose (GO:0009749)	4	0	.05	-	 < 0.01	1.00E00
protein N-linked glycosylation (GO:0006487)	34	0	.41	-	 < 0.01	1.00E00
protein glycosylation (GO:0006486)	86	0	1.04	-	 < 0.01	6.29E-01
carbohydrate derivative catabolic process (GO:1901136)	56	0	.68	-	 < 0.01	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	3	0	.04	-	 < 0.01	1.00E00
protein localization to kinetochore (GO:0034501)	5	0	.06	-	 < 0.01	1.00E00
regulation of circadian rhythm (GO:0042752)	8	0	.10	-	 < 0.01	1.00E00
amino acid biosynthetic process (GO:0008652)	22	0	.27	-	 < 0.01	1.00E00
protein import into mitochondrial matrix (GO:0030150)	10	0	.12	-	 < 0.01	1.00E00
alanine transport (GO:0032328)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	18	0	.22	-	 < 0.01	1.00E00
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	25	0	.30	-	 < 0.01	1.00E00
oxidative phosphorylation (GO:0006119)	6	0	.07	-	 < 0.01	1.00E00
protein acetylation (GO:0006473)	5	0	.06	-	 < 0.01	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	2	0	.02	-	 < 0.01	1.00E00
protein dephosphorylation (GO:0006470)	48	0	.58	-	 < 0.01	1.00E00
sphingolipid catabolic process (GO:0030149)	10	0	.12	-	 < 0.01	1.00E00
defense response to bacterium (GO:0042742)	5	0	.06	-	 < 0.01	1.00E00
sphingolipid biosynthetic process (GO:0030148)	37	0	.45	-	 < 0.01	1.00E00
carbohydrate transport (GO:0008643)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of protein kinase activity (GO:0006469)	30	0	.36	-	 < 0.01	1.00E00
response to hormone (GO:0009725)	70	0	.84	-	 < 0.01	1.00E00
signal peptide processing (GO:0006465)	4	0	.05	-	 < 0.01	1.00E00
sister chromatid segregation (GO:0000819)	38	0	.46	-	 < 0.01	1.00E00
apoptotic mitochondrial changes (GO:0008637)	10	0	.12	-	 < 0.01	1.00E00
proteinogenic amino acid metabolic process (GO:0170039)	37	0	.45	-	 < 0.01	1.00E00
proteinogenic amino acid biosynthetic process (GO:0170038)	20	0	.24	-	 < 0.01	1.00E00
negative regulation of angiogenesis (GO:0016525)	8	0	.10	-	 < 0.01	1.00E00
detection of mechanical stimulus (GO:0050982)	7	0	.08	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	11	0	.13	-	 < 0.01	1.00E00
L-amino acid biosynthetic process (GO:0170034)	20	0	.24	-	 < 0.01	1.00E00
L-amino acid metabolic process (GO:0170033)	46	0	.55	-	 < 0.01	1.00E00
negative regulation of chromosome separation (GO:1905819)	9	0	.11	-	 < 0.01	1.00E00
sex differentiation (GO:0007548)	4	0	.05	-	 < 0.01	1.00E00
regulation of chromosome separation (GO:1905818)	14	0	.17	-	 < 0.01	1.00E00
maturation of SSU-rRNA (GO:0030490)	26	0	.31	-	 < 0.01	1.00E00
response to endogenous stimulus (GO:0009719)	166	0	2.00	-	 < 0.01	2.72E-01
response to other organism (GO:0051707)	39	0	.47	-	 < 0.01	1.00E00
'de novo' protein folding (GO:0006458)	8	0	.10	-	 < 0.01	1.00E00
protein folding (GO:0006457)	88	0	1.06	-	 < 0.01	6.29E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	9	0	.11	-	 < 0.01	1.00E00
biological process involved in interaction with host (GO:0051701)	1	0	.01	-	 < 0.01	1.00E00
RNA decapping (GO:0110154)	8	0	.10	-	 < 0.01	1.00E00
biomineral tissue development (GO:0031214)	4	0	.05	-	 < 0.01	1.00E00
mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	4	0	.05	-	 < 0.01	1.00E00
DNA integrity checkpoint signaling (GO:0031570)	22	0	.27	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	3	0	.04	-	 < 0.01	1.00E00
tRNA methylation (GO:0030488)	17	0	.21	-	 < 0.01	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	4	0	.05	-	 < 0.01	1.00E00
regulation of translational initiation (GO:0006446)	10	0	.12	-	 < 0.01	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	4	0	.05	-	 < 0.01	1.00E00
tRNA wobble uridine modification (GO:0002098)	6	0	.07	-	 < 0.01	1.00E00
regulation of Wnt signaling pathway (GO:0030111)	55	0	.66	-	 < 0.01	1.00E00
positive regulation of intracellular signal transduction (GO:1902533)	125	0	1.51	-	 < 0.01	4.09E-01
negative regulation of intracellular signal transduction (GO:1902532)	57	0	.69	-	 < 0.01	1.00E00
regulation of intracellular signal transduction (GO:1902531)	238	0	2.87	-	 < 0.01	1.22E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	7	0	.08	-	 < 0.01	1.00E00
lens development in camera-type eye (GO:0002088)	16	0	.19	-	 < 0.01	1.00E00
organelle transport along microtubule (GO:0072384)	25	0	.30	-	 < 0.01	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	9	0	.11	-	 < 0.01	1.00E00
skeletal muscle tissue development (GO:0007519)	13	0	.16	-	 < 0.01	1.00E00
regulation of endocytosis (GO:0030100)	19	0	.23	-	 < 0.01	1.00E00
muscle organ development (GO:0007517)	18	0	.22	-	 < 0.01	1.00E00
positive regulation of innate immune response (GO:0045089)	18	0	.22	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	17	0	.21	-	 < 0.01	1.00E00
regulation of innate immune response (GO:0045088)	23	0	.28	-	 < 0.01	1.00E00
innate immune response (GO:0045087)	24	0	.29	-	 < 0.01	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	5	0	.06	-	 < 0.01	1.00E00
heme biosynthetic process (GO:0006783)	5	0	.06	-	 < 0.01	1.00E00
alcohol biosynthetic process (GO:0046165)	30	0	.36	-	 < 0.01	1.00E00
regulation of translation (GO:0006417)	45	0	.54	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	6	0	.07	-	 < 0.01	1.00E00
mesoderm morphogenesis (GO:0048332)	7	0	.08	-	 < 0.01	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	10	0	.12	-	 < 0.01	1.00E00
translational termination (GO:0006415)	3	0	.04	-	 < 0.01	1.00E00
translational elongation (GO:0006414)	18	0	.22	-	 < 0.01	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	10	0	.12	-	 < 0.01	1.00E00
regulation of complement activation (GO:0030449)	1	0	.01	-	 < 0.01	1.00E00
organophosphate ester transport (GO:0015748)	46	0	.55	-	 < 0.01	1.00E00
citrate transport (GO:0015746)	3	0	.04	-	 < 0.01	1.00E00
succinate transport (GO:0015744)	3	0	.04	-	 < 0.01	1.00E00
mRNA export from nucleus (GO:0006406)	24	0	.29	-	 < 0.01	1.00E00
C4-dicarboxylate transport (GO:0015740)	12	0	.14	-	 < 0.01	1.00E00
RNA export from nucleus (GO:0006405)	30	0	.36	-	 < 0.01	1.00E00
RNA localization (GO:0006403)	38	0	.46	-	 < 0.01	1.00E00
tRNA modification (GO:0006400)	37	0	.45	-	 < 0.01	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	8	0	.10	-	 < 0.01	1.00E00
pigment biosynthetic process (GO:0046148)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of chemotaxis (GO:0050921)	7	0	.08	-	 < 0.01	1.00E00
regulation of chemotaxis (GO:0050920)	7	0	.08	-	 < 0.01	1.00E00
mitotic spindle assembly (GO:0090307)	12	0	.14	-	 < 0.01	1.00E00
regulated exocytosis (GO:0045055)	28	0	.34	-	 < 0.01	1.00E00
axon extension (GO:0048675)	2	0	.02	-	 < 0.01	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	36	0	.43	-	 < 0.01	1.00E00
regulation of membrane lipid distribution (GO:0097035)	25	0	.30	-	 < 0.01	1.00E00
positive chemotaxis (GO:0050918)	2	0	.02	-	 < 0.01	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	38	0	.46	-	 < 0.01	1.00E00
sensory perception of bitter taste (GO:0050913)	1	0	.01	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	1	0	.01	-	 < 0.01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	4	0	.05	-	 < 0.01	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	27	0	.33	-	 < 0.01	1.00E00
sprouting angiogenesis (GO:0002040)	8	0	.10	-	 < 0.01	1.00E00
synaptic membrane adhesion (GO:0099560)	5	0	.06	-	 < 0.01	1.00E00
protein insertion into ER membrane (GO:0045048)	3	0	.04	-	 < 0.01	1.00E00
cell morphogenesis involved in neuron differentiation (GO:0048667)	120	0	1.45	-	 < 0.01	4.08E-01
glutathione metabolic process (GO:0006749)	14	0	.17	-	 < 0.01	1.00E00
bile acid and bile salt transport (GO:0015721)	5	0	.06	-	 < 0.01	1.00E00
ubiquinone biosynthetic process (GO:0006744)	5	0	.06	-	 < 0.01	1.00E00
sensory perception of taste (GO:0050909)	2	0	.02	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	2	0	.02	-	 < 0.01	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	6	0	.07	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	4	0	.05	-	 < 0.01	1.00E00
signal transduction by p53 class mediator (GO:0072331)	5	0	.06	-	 < 0.01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	25	0	.30	-	 < 0.01	1.00E00
leukocyte migration (GO:0050900)	7	0	.08	-	 < 0.01	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	3	0	.04	-	 < 0.01	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	5	0	.06	-	 < 0.01	1.00E00
NADP metabolic process (GO:0006739)	4	0	.05	-	 < 0.01	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	33	0	.40	-	 < 0.01	1.00E00
regulation of sodium ion transport (GO:0002028)	19	0	.23	-	 < 0.01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	8	0	.10	-	 < 0.01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	7	0	.08	-	 < 0.01	1.00E00
SREBP signaling pathway (GO:0032933)	6	0	.07	-	 < 0.01	1.00E00
anatomical structure formation involved in morphogenesis (GO:0048646)	80	0	.97	-	 < 0.01	1.00E00
early endosome to late endosome transport (GO:0045022)	4	0	.05	-	 < 0.01	1.00E00
activation of GTPase activity (GO:0090630)	34	0	.41	-	 < 0.01	1.00E00
lymphocyte migration (GO:0072676)	2	0	.02	-	 < 0.01	1.00E00
monosaccharide metabolic process (GO:0005996)	24	0	.29	-	 < 0.01	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	11	0	.13	-	 < 0.01	1.00E00
membrane lipid biosynthetic process (GO:0046467)	53	0	.64	-	 < 0.01	1.00E00
acylglycerol catabolic process (GO:0046464)	9	0	.11	-	 < 0.01	1.00E00
canonical Wnt signaling pathway (GO:0060070)	52	0	.63	-	 < 0.01	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	8	0	.10	-	 < 0.01	1.00E00
neutral lipid catabolic process (GO:0046461)	9	0	.11	-	 < 0.01	1.00E00
activin receptor signaling pathway (GO:0032924)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of developmental process (GO:0051094)	70	0	.84	-	 < 0.01	1.00E00
circadian regulation of gene expression (GO:0032922)	19	0	.23	-	 < 0.01	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	11	0	.13	-	 < 0.01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	16	0	.19	-	 < 0.01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	24	0	.29	-	 < 0.01	1.00E00
morphogenesis of an epithelium (GO:0002009)	12	0	.14	-	 < 0.01	1.00E00
small molecule biosynthetic process (GO:0044283)	102	0	1.23	-	 < 0.01	6.38E-01
small molecule catabolic process (GO:0044282)	81	0	.98	-	 < 0.01	1.00E00
leukocyte activation involved in immune response (GO:0002366)	3	0	.04	-	 < 0.01	1.00E00
TORC2 signaling (GO:0038203)	4	0	.05	-	 < 0.01	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	8	0	.10	-	 < 0.01	1.00E00
TORC1 signaling (GO:0038202)	1	0	.01	-	 < 0.01	1.00E00
endomembrane system organization (GO:0010256)	105	0	1.27	-	 < 0.01	6.40E-01
icosanoid biosynthetic process (GO:0046456)	5	0	.06	-	 < 0.01	1.00E00
cellular response to biotic stimulus (GO:0071216)	8	0	.10	-	 < 0.01	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	8	0	.10	-	 < 0.01	1.00E00
leucine biosynthetic process (GO:0009098)	1	0	.01	-	 < 0.01	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	18	0	.22	-	 < 0.01	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	6	0	.07	-	 < 0.01	1.00E00
response to oxygen levels (GO:0070482)	17	0	.21	-	 < 0.01	1.00E00
protein localization to plasma membrane (GO:0072659)	43	0	.52	-	 < 0.01	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	11	0	.13	-	 < 0.01	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	20	0	.24	-	 < 0.01	1.00E00
sulfur compound catabolic process (GO:0044273)	7	0	.08	-	 < 0.01	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	16	0	.19	-	 < 0.01	1.00E00
tube development (GO:0035295)	38	0	.46	-	 < 0.01	1.00E00
response to organonitrogen compound (GO:0010243)	79	0	.95	-	 < 0.01	1.00E00
lysine biosynthetic process (GO:0009085)	1	0	.01	-	 < 0.01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	19	0	.23	-	 < 0.01	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.02	-	 < 0.01	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	9	0	.11	-	 < 0.01	1.00E00
rRNA base methylation (GO:0070475)	5	0	.06	-	 < 0.01	1.00E00
ncRNA transcription (GO:0098781)	12	0	.14	-	 < 0.01	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	28	0	.34	-	 < 0.01	1.00E00
cellular response to oxygen-containing compound (GO:1901701)	80	0	.97	-	 < 0.01	1.00E00
receptor signaling pathway via STAT (GO:0097696)	5	0	.06	-	 < 0.01	1.00E00
response to oxygen-containing compound (GO:1901700)	99	0	1.19	-	 < 0.01	6.35E-01
cardiac muscle contraction (GO:0060048)	13	0	.16	-	 < 0.01	1.00E00
heart contraction (GO:0060047)	17	0	.21	-	 < 0.01	1.00E00
response to transforming growth factor beta (GO:0071559)	19	0	.23	-	 < 0.01	1.00E00
organophosphate catabolic process (GO:0046434)	42	0	.51	-	 < 0.01	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	6	0	.07	-	 < 0.01	1.00E00
retina development in camera-type eye (GO:0060041)	1	0	.01	-	 < 0.01	1.00E00
multicellular organismal reproductive process (GO:0048609)	28	0	.34	-	 < 0.01	1.00E00
cellular response to amino acid starvation (GO:0034198)	9	0	.11	-	 < 0.01	1.00E00
peptide catabolic process (GO:0043171)	9	0	.11	-	 < 0.01	1.00E00
reproductive structure development (GO:0048608)	2	0	.02	-	 < 0.01	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	9	0	.11	-	 < 0.01	1.00E00
aromatic amino acid metabolic process (GO:0009072)	12	0	.14	-	 < 0.01	1.00E00
inorganic ion homeostasis (GO:0098771)	89	0	1.07	-	 < 0.01	6.30E-01
MAPK cascade (GO:0000165)	18	0	.22	-	 < 0.01	1.00E00
regulation of immune effector process (GO:0002697)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of leukocyte activation (GO:0002696)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	2	0	.02	-	 < 0.01	1.00E00
negative regulation of leukocyte activation (GO:0002695)	6	0	.07	-	 < 0.01	1.00E00
regulation of leukocyte activation (GO:0002694)	11	0	.13	-	 < 0.01	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	6	0	.07	-	 < 0.01	1.00E00
microtubule polymerization (GO:0046785)	19	0	.23	-	 < 0.01	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	7	0	.08	-	 < 0.01	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	8	0	.10	-	 < 0.01	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	8	0	.10	-	 < 0.01	1.00E00
regulation of small GTPase mediated signal transduction (GO:0051056)	42	0	.51	-	 < 0.01	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	12	0	.14	-	 < 0.01	1.00E00
amino acid catabolic process (GO:0009063)	31	0	.37	-	 < 0.01	1.00E00
regulation of DNA metabolic process (GO:0051052)	32	0	.39	-	 < 0.01	1.00E00
fatty acid catabolic process (GO:0009062)	30	0	.36	-	 < 0.01	1.00E00
negative regulation of transport (GO:0051051)	29	0	.35	-	 < 0.01	1.00E00
positive regulation of transport (GO:0051050)	34	0	.41	-	 < 0.01	1.00E00
aerobic respiration (GO:0009060)	21	0	.25	-	 < 0.01	1.00E00
cellular respiration (GO:0045333)	26	0	.31	-	 < 0.01	1.00E00
phospholipid translocation (GO:0045332)	21	0	.25	-	 < 0.01	1.00E00
intraciliary transport (GO:0042073)	17	0	.21	-	 < 0.01	1.00E00
rRNA modification (GO:0000154)	17	0	.21	-	 < 0.01	1.00E00
mitochondrial gene expression (GO:0140053)	23	0	.28	-	 < 0.01	1.00E00
protein O-linked mannosylation (GO:0035269)	5	0	.06	-	 < 0.01	1.00E00
cellular lipid catabolic process (GO:0044242)	60	0	.72	-	 < 0.01	1.00E00
protein mannosylation (GO:0035268)	8	0	.10	-	 < 0.01	1.00E00
positive regulation of leukocyte migration (GO:0002687)	10	0	.12	-	 < 0.01	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	56	0	.68	-	 < 0.01	1.00E00
regulation of leukocyte migration (GO:0002685)	13	0	.16	-	 < 0.01	1.00E00
positive regulation of immune system process (GO:0002684)	66	0	.80	-	 < 0.01	1.00E00
negative regulation of immune system process (GO:0002683)	16	0	.19	-	 < 0.01	1.00E00
regulation of immune system process (GO:0002682)	95	0	1.15	-	 < 0.01	6.32E-01
DNA biosynthetic process (GO:0071897)	17	0	.21	-	 < 0.01	1.00E00
positive regulation of secretion (GO:0051047)	6	0	.07	-	 < 0.01	1.00E00
regulation of monoatomic cation transmembrane transport (GO:1904062)	43	0	.52	-	 < 0.01	1.00E00
detoxification (GO:0098754)	6	0	.07	-	 < 0.01	1.00E00
late endosome to vacuole transport (GO:0045324)	24	0	.29	-	 < 0.01	1.00E00
gliogenesis (GO:0042063)	12	0	.14	-	 < 0.01	1.00E00
protein localization to lysosome (GO:0061462)	6	0	.07	-	 < 0.01	1.00E00
stress fiber assembly (GO:0043149)	5	0	.06	-	 < 0.01	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	6	0	.07	-	 < 0.01	1.00E00
regulation of cell cycle process (GO:0010564)	99	0	1.19	-	 < 0.01	6.35E-01
negative regulation of phosphorus metabolic process (GO:0010563)	36	0	.43	-	 < 0.01	1.00E00
neuron projection extension (GO:1990138)	5	0	.06	-	 < 0.01	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	10	0	.12	-	 < 0.01	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	63	0	.76	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	1	0	.01	-	 < 0.01	1.00E00
reproductive system development (GO:0061458)	2	0	.02	-	 < 0.01	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	9	0	.11	-	 < 0.01	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	17	0	.21	-	 < 0.01	1.00E00
mRNA transport (GO:0051028)	26	0	.31	-	 < 0.01	1.00E00
import across plasma membrane (GO:0098739)	65	0	.78	-	 < 0.01	1.00E00
microtubule bundle formation (GO:0001578)	18	0	.22	-	 < 0.01	1.00E00
phospholipid catabolic process (GO:0009395)	12	0	.14	-	 < 0.01	1.00E00
kinetochore organization (GO:0051383)	8	0	.10	-	 < 0.01	1.00E00
kinetochore assembly (GO:0051382)	6	0	.07	-	 < 0.01	1.00E00
fluid transport (GO:0042044)	6	0	.07	-	 < 0.01	1.00E00
regulation of neuron differentiation (GO:0045664)	9	0	.11	-	 < 0.01	1.00E00
vasculogenesis (GO:0001570)	3	0	.04	-	 < 0.01	1.00E00
exocytic process (GO:0140029)	13	0	.16	-	 < 0.01	1.00E00
endosomal transport (GO:0016197)	93	0	1.12	-	 < 0.01	6.31E-01
tube morphogenesis (GO:0035239)	36	0	.43	-	 < 0.01	1.00E00
RNA stabilization (GO:0043489)	11	0	.13	-	 < 0.01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	17	0	.21	-	 < 0.01	1.00E00
negative regulation of canonical NF-kappaB signal transduction (GO:0043124)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of canonical NF-kappaB signal transduction (GO:0043123)	21	0	.25	-	 < 0.01	1.00E00
actin filament bundle assembly (GO:0051017)	18	0	.22	-	 < 0.01	1.00E00
regulation of canonical NF-kappaB signal transduction (GO:0043122)	30	0	.36	-	 < 0.01	1.00E00
barbed-end actin filament capping (GO:0051016)	17	0	.21	-	 < 0.01	1.00E00
blood vessel development (GO:0001568)	35	0	.42	-	 < 0.01	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	4	0	.05	-	 < 0.01	1.00E00
isoprenoid biosynthetic process (GO:0008299)	9	0	.11	-	 < 0.01	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	4	0	.05	-	 < 0.01	1.00E00
regulation of membrane potential (GO:0042391)	86	0	1.04	-	 < 0.01	6.29E-01
mitotic nuclear division (GO:0140014)	38	0	.46	-	 < 0.01	1.00E00
meiotic nuclear division (GO:0140013)	32	0	.39	-	 < 0.01	1.00E00
maturation of LSU-rRNA (GO:0000470)	17	0	.21	-	 < 0.01	1.00E00
snRNA processing (GO:0016180)	19	0	.23	-	 < 0.01	1.00E00
bone development (GO:0060348)	6	0	.07	-	 < 0.01	1.00E00
regulation of protein localization to membrane (GO:1905475)	10	0	.12	-	 < 0.01	1.00E00
pigmentation (GO:0043473)	11	0	.13	-	 < 0.01	1.00E00
regulation of cell growth (GO:0001558)	10	0	.12	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	9	0	.11	-	 < 0.01	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	10	0	.12	-	 < 0.01	1.00E00
insulin receptor signaling pathway (GO:0008286)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	9	0	.11	-	 < 0.01	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of cell population proliferation (GO:0008285)	14	0	.17	-	 < 0.01	1.00E00
regulation of sister chromatid segregation (GO:0033045)	18	0	.22	-	 < 0.01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	55	0	.66	-	 < 0.01	1.00E00
regulation of chromosome organization (GO:0033044)	29	0	.35	-	 < 0.01	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	11	0	.13	-	 < 0.01	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	16	0	.19	-	 < 0.01	1.00E00
triglyceride catabolic process (GO:0019433)	3	0	.04	-	 < 0.01	1.00E00
triglyceride biosynthetic process (GO:0019432)	9	0	.11	-	 < 0.01	1.00E00
maturation of 5.8S rRNA (GO:0000460)	15	0	.18	-	 < 0.01	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	4	0	.05	-	 < 0.01	1.00E00
type I interferon-mediated signaling pathway (GO:0060337)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	2	0	.02	-	 < 0.01	1.00E00
protein palmitoylation (GO:0018345)	20	0	.24	-	 < 0.01	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	4	0	.05	-	 < 0.01	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	6	0	.07	-	 < 0.01	1.00E00
negative regulation of lyase activity (GO:0051350)	2	0	.02	-	 < 0.01	1.00E00
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	16	0	.19	-	 < 0.01	1.00E00
non-canonical Wnt signaling pathway (GO:0035567)	25	0	.30	-	 < 0.01	1.00E00
cell chemotaxis (GO:0060326)	15	0	.18	-	 < 0.01	1.00E00
regulation of phospholipase activity (GO:0010517)	1	0	.01	-	 < 0.01	1.00E00
lipid localization (GO:0010876)	80	0	.97	-	 < 0.01	1.00E00
positive regulation of lyase activity (GO:0051349)	9	0	.11	-	 < 0.01	1.00E00
head development (GO:0060322)	45	0	.54	-	 < 0.01	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	12	0	.14	-	 < 0.01	1.00E00
tricarboxylic acid cycle (GO:0006099)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of hydrolase activity (GO:0051346)	24	0	.29	-	 < 0.01	1.00E00
positive regulation of hydrolase activity (GO:0051345)	66	0	.80	-	 < 0.01	1.00E00
glycolytic process (GO:0006096)	14	0	.17	-	 < 0.01	1.00E00
retina homeostasis (GO:0001895)	2	0	.02	-	 < 0.01	1.00E00
tissue homeostasis (GO:0001894)	4	0	.05	-	 < 0.01	1.00E00
snRNA 3'-end processing (GO:0034472)	17	0	.21	-	 < 0.01	1.00E00
amino acid import across plasma membrane (GO:0089718)	9	0	.11	-	 < 0.01	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	2	0	.02	-	 < 0.01	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	19	0	.23	-	 < 0.01	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	30	0	.36	-	 < 0.01	1.00E00
positive regulation of autophagy (GO:0010508)	16	0	.19	-	 < 0.01	1.00E00
negative regulation of autophagy (GO:0010507)	9	0	.11	-	 < 0.01	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	11	0	.13	-	 < 0.01	1.00E00
regulation of autophagy (GO:0010506)	35	0	.42	-	 < 0.01	1.00E00
protein-RNA complex organization (GO:0071826)	67	0	.81	-	 < 0.01	1.00E00
regulation of lyase activity (GO:0051339)	12	0	.14	-	 < 0.01	1.00E00
regulation of hydrolase activity (GO:0051336)	114	0	1.38	-	 < 0.01	6.50E-01
liver development (GO:0001889)	2	0	.02	-	 < 0.01	1.00E00
angiogenesis (GO:0001525)	31	0	.37	-	 < 0.01	1.00E00
regulation of tissue remodeling (GO:0034103)	3	0	.04	-	 < 0.01	1.00E00
regulation of autophagosome maturation (GO:1901096)	5	0	.06	-	 < 0.01	1.00E00
pseudouridine synthesis (GO:0001522)	11	0	.13	-	 < 0.01	1.00E00
tetrapyrrole metabolic process (GO:0033013)	12	0	.14	-	 < 0.01	1.00E00
non-membrane-bounded organelle assembly (GO:0140694)	89	0	1.07	-	 < 0.01	6.30E-01
negative regulation of cell adhesion (GO:0007162)	10	0	.12	-	 < 0.01	1.00E00
response to peptide hormone (GO:0043434)	24	0	.29	-	 < 0.01	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	8	0	.10	-	 < 0.01	1.00E00
meiotic cell cycle (GO:0051321)	49	0	.59	-	 < 0.01	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	3	0	.04	-	 < 0.01	1.00E00
RNA methylation (GO:0001510)	38	0	.46	-	 < 0.01	1.00E00
mitophagy (GO:0000423)	11	0	.13	-	 < 0.01	1.00E00
secretory granule organization (GO:0033363)	2	0	.02	-	 < 0.01	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	1	0	.01	-	 < 0.01	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	15	0	.18	-	 < 0.01	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	23	0	.28	-	 < 0.01	1.00E00
positive regulation of protein polymerization (GO:0032273)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of protein polymerization (GO:0032272)	22	0	.27	-	 < 0.01	1.00E00
potassium ion transmembrane transport (GO:0071805)	86	0	1.04	-	 < 0.01	6.29E-01
regulation of protein polymerization (GO:0032271)	46	0	.55	-	 < 0.01	1.00E00
action potential (GO:0001508)	30	0	.36	-	 < 0.01	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	0	.06	-	 < 0.01	1.00E00
ossification (GO:0001503)	12	0	.14	-	 < 0.01	1.00E00
metaphase chromosome alignment (GO:0051310)	9	0	.11	-	 < 0.01	1.00E00
skeletal system development (GO:0001501)	28	0	.34	-	 < 0.01	1.00E00
protein localization to cell periphery (GO:1990778)	50	0	.60	-	 < 0.01	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	3	0	.04	-	 < 0.01	1.00E00
lipid oxidation (GO:0034440)	23	0	.28	-	 < 0.01	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	2	0	.02	-	 < 0.01	1.00E00
myeloid cell differentiation (GO:0030099)	9	0	.11	-	 < 0.01	1.00E00
taxis (GO:0042330)	33	0	.40	-	 < 0.01	1.00E00
muscle cell differentiation (GO:0042692)	37	0	.45	-	 < 0.01	1.00E00
phytosteroid metabolic process (GO:0016128)	1	0	.01	-	 < 0.01	1.00E00
secondary metabolic process (GO:0019748)	5	0	.06	-	 < 0.01	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	12	0	.14	-	 < 0.01	1.00E00
sterol biosynthetic process (GO:0016126)	12	0	.14	-	 < 0.01	1.00E00
regulation of Notch signaling pathway (GO:0008593)	12	0	.14	-	 < 0.01	1.00E00
sterol metabolic process (GO:0016125)	20	0	.24	-	 < 0.01	1.00E00
cytosolic transport (GO:0016482)	35	0	.42	-	 < 0.01	1.00E00
male meiotic nuclear division (GO:0007140)	4	0	.05	-	 < 0.01	1.00E00
macromolecule glycosylation (GO:0043413)	86	0	1.04	-	 < 0.01	6.29E-01
positive regulation of MAPK cascade (GO:0043410)	67	0	.81	-	 < 0.01	1.00E00
chromosome separation (GO:0051304)	1	0	.01	-	 < 0.01	1.00E00
response to radiation (GO:0009314)	29	0	.35	-	 < 0.01	1.00E00
establishment of chromosome localization (GO:0051303)	13	0	.16	-	 < 0.01	1.00E00
regulation of cell division (GO:0051302)	7	0	.08	-	 < 0.01	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	2	0	.02	-	 < 0.01	1.00E00
cell division (GO:0051301)	34	0	.41	-	 < 0.01	1.00E00
negative regulation of phosphorylation (GO:0042326)	32	0	.39	-	 < 0.01	1.00E00
positive regulation of transcription by RNA polymerase I (GO:0045943)	3	0	.04	-	 < 0.01	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	3	0	.04	-	 < 0.01	1.00E00
carotenoid biosynthetic process (GO:0016117)	1	0	.01	-	 < 0.01	1.00E00
male gonad development (GO:0008584)	1	0	.01	-	 < 0.01	1.00E00
cholesterol efflux (GO:0033344)	8	0	.10	-	 < 0.01	1.00E00
terpenoid biosynthetic process (GO:0016114)	2	0	.02	-	 < 0.01	1.00E00
antimicrobial humoral response (GO:0019730)	1	0	.01	-	 < 0.01	1.00E00
mesoderm development (GO:0007498)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of MAPK cascade (GO:0043409)	24	0	.29	-	 < 0.01	1.00E00
regulation of MAPK cascade (GO:0043408)	113	0	1.36	-	 < 0.01	6.49E-01
reciprocal meiotic recombination (GO:0007131)	20	0	.24	-	 < 0.01	1.00E00
regulation of MAP kinase activity (GO:0043405)	20	0	.24	-	 < 0.01	1.00E00
endoderm development (GO:0007492)	7	0	.08	-	 < 0.01	1.00E00
amine metabolic process (GO:0009308)	17	0	.21	-	 < 0.01	1.00E00
regulation of centrosome duplication (GO:0010824)	6	0	.07	-	 < 0.01	1.00E00
protein secretion (GO:0009306)	17	0	.21	-	 < 0.01	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	3	0	.04	-	 < 0.01	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	5	0	.06	-	 < 0.01	1.00E00
regulation of mitochondrion organization (GO:0010821)	9	0	.11	-	 < 0.01	1.00E00
rRNA transcription (GO:0009303)	6	0	.07	-	 < 0.01	1.00E00
rRNA methylation (GO:0031167)	10	0	.12	-	 < 0.01	1.00E00
phagolysosome assembly (GO:0001845)	9	0	.11	-	 < 0.01	1.00E00
spindle localization (GO:0051653)	17	0	.21	-	 < 0.01	1.00E00
negative regulation of phosphate metabolic process (GO:0045936)	36	0	.43	-	 < 0.01	1.00E00
maintenance of location in cell (GO:0051651)	18	0	.22	-	 < 0.01	1.00E00
amino sugar metabolic process (GO:0006040)	14	0	.17	-	 < 0.01	1.00E00
cell death (GO:0008219)	58	0	.70	-	 < 0.01	1.00E00
regulation of blood pressure (GO:0008217)	12	0	.14	-	 < 0.01	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	14	0	.17	-	 < 0.01	1.00E00
negative regulation of mitotic cell cycle (GO:0045930)	36	0	.43	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	9	0	.11	-	 < 0.01	1.00E00
insulin secretion (GO:0030073)	2	0	.02	-	 < 0.01	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	6	0	.07	-	 < 0.01	1.00E00
peptide hormone secretion (GO:0030072)	3	0	.04	-	 < 0.01	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	15	0	.18	-	 < 0.01	1.00E00
cell cycle G1/S phase transition (GO:0044843)	17	0	.21	-	 < 0.01	1.00E00
meiosis I (GO:0007127)	25	0	.30	-	 < 0.01	1.00E00
positive regulation of cell-substrate adhesion (GO:0010811)	11	0	.13	-	 < 0.01	1.00E00
regulation of cell-substrate adhesion (GO:0010810)	13	0	.16	-	 < 0.01	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of growth (GO:0045927)	3	0	.04	-	 < 0.01	1.00E00
mitochondrial transcription (GO:0006390)	6	0	.07	-	 < 0.01	1.00E00
reticulophagy (GO:0061709)	8	0	.10	-	 < 0.01	1.00E00
cholesterol metabolic process (GO:0008203)	14	0	.17	-	 < 0.01	1.00E00
cell cycle G2/M phase transition (GO:0044839)	3	0	.04	-	 < 0.01	1.00E00
steroid metabolic process (GO:0008202)	26	0	.31	-	 < 0.01	1.00E00
left/right pattern formation (GO:0060972)	2	0	.02	-	 < 0.01	1.00E00
glucose transmembrane transport (GO:1904659)	5	0	.06	-	 < 0.01	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	4	0	.05	-	 < 0.01	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	11	0	.13	-	 < 0.01	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	14	0	.17	-	 < 0.01	1.00E00
aminoglycan biosynthetic process (GO:0006023)	15	0	.18	-	 < 0.01	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	7	0	.08	-	 < 0.01	1.00E00
regulation of monoatomic ion transmembrane transport (GO:0034765)	57	0	.69	-	 < 0.01	1.00E00
aminoglycan metabolic process (GO:0006022)	22	0	.27	-	 < 0.01	1.00E00
transcription by RNA polymerase III (GO:0006383)	13	0	.16	-	 < 0.01	1.00E00
adenosine to inosine editing (GO:0006382)	4	0	.05	-	 < 0.01	1.00E00
regulation of transmembrane transport (GO:0034762)	67	0	.81	-	 < 0.01	1.00E00
negative regulation of DNA recombination (GO:0045910)	5	0	.06	-	 < 0.01	1.00E00
mitotic DNA replication checkpoint signaling (GO:0033314)	3	0	.04	-	 < 0.01	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	13	0	.16	-	 < 0.01	1.00E00
somatic cell DNA recombination (GO:0016444)	2	0	.02	-	 < 0.01	1.00E00
regulation of organelle assembly (GO:1902115)	21	0	.25	-	 < 0.01	1.00E00
chloride transmembrane transport (GO:1902476)	32	0	.39	-	 < 0.01	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	13	0	.16	-	 < 0.01	1.00E00
regulation of cellular response to growth factor stimulus (GO:0090287)	42	0	.51	-	 < 0.01	1.00E00
positive regulation of cytokine production (GO:0001819)	8	0	.10	-	 < 0.01	1.00E00
regulation of cytokine production (GO:0001817)	22	0	.27	-	 < 0.01	1.00E00
mRNA polyadenylation (GO:0006378)	5	0	.06	-	 < 0.01	1.00E00
response to toxic substance (GO:0009636)	8	0	.10	-	 < 0.01	1.00E00
cytokine production (GO:0001816)	5	0	.06	-	 < 0.01	1.00E00
mRNA splice site recognition (GO:0006376)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of chromosome segregation (GO:0051985)	9	0	.11	-	 < 0.01	1.00E00
iron ion transmembrane transport (GO:0034755)	4	0	.05	-	 < 0.01	1.00E00
regulation of chromosome segregation (GO:0051983)	20	0	.24	-	 < 0.01	1.00E00
DNA double-strand break processing (GO:0000729)	4	0	.05	-	 < 0.01	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	9	0	.11	-	 < 0.01	1.00E00
actin filament-based movement (GO:0030048)	13	0	.16	-	 < 0.01	1.00E00
recombinational repair (GO:0000725)	53	0	.64	-	 < 0.01	1.00E00
epidermis development (GO:0008544)	4	0	.05	-	 < 0.01	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	11	0	.13	-	 < 0.01	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	53	0	.64	-	 < 0.01	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	24	0	.29	-	 < 0.01	1.00E00
actin filament depolymerization (GO:0030042)	8	0	.10	-	 < 0.01	1.00E00
actin filament polymerization (GO:0030041)	10	0	.12	-	 < 0.01	1.00E00
regulation of peptide hormone secretion (GO:0090276)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	9	0	.11	-	 < 0.01	1.00E00
organelle fission (GO:0048285)	77	0	.93	-	 < 0.01	1.00E00
response to abiotic stimulus (GO:0009628)	69	0	.83	-	 < 0.01	1.00E00
glucose metabolic process (GO:0006006)	14	0	.17	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase II (GO:0006368)	9	0	.11	-	 < 0.01	1.00E00
cell-cell recognition (GO:0009988)	1	0	.01	-	 < 0.01	1.00E00
transcription initiation at RNA polymerase II promoter (GO:0006367)	21	0	.25	-	 < 0.01	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	13	0	.16	-	 < 0.01	1.00E00
transcription by RNA polymerase II (GO:0006366)	46	0	.55	-	 < 0.01	1.00E00
rRNA processing (GO:0006364)	80	0	.97	-	 < 0.01	1.00E00
mRNA 3'-end processing (GO:0031124)	16	0	.19	-	 < 0.01	1.00E00
RNA 3'-end processing (GO:0031123)	40	0	.48	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase I (GO:0006362)	2	0	.02	-	 < 0.01	1.00E00
cytoplasmic microtubule organization (GO:0031122)	21	0	.25	-	 < 0.01	1.00E00
transcription by RNA polymerase I (GO:0006360)	10	0	.12	-	 < 0.01	1.00E00
lipid homeostasis (GO:0055088)	23	0	.28	-	 < 0.01	1.00E00
cholesterol homeostasis (GO:0042632)	8	0	.10	-	 < 0.01	1.00E00
contractile actin filament bundle assembly (GO:0030038)	5	0	.06	-	 < 0.01	1.00E00
respiratory chain complex IV assembly (GO:0008535)	1	0	.01	-	 < 0.01	1.00E00
regulation of trans-synaptic signaling (GO:0099177)	77	0	.93	-	 < 0.01	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	11	0	.13	-	 < 0.01	1.00E00
regulation of postsynapse organization (GO:0099175)	7	0	.08	-	 < 0.01	1.00E00
postsynapse organization (GO:0099173)	4	0	.05	-	 < 0.01	1.00E00
homologous recombination (GO:0035825)	20	0	.24	-	 < 0.01	1.00E00
regulation of telomere maintenance (GO:0032204)	6	0	.07	-	 < 0.01	1.00E00
inorganic anion transport (GO:0015698)	45	0	.54	-	 < 0.01	1.00E00
quaternary ammonium group transport (GO:0015697)	5	0	.06	-	 < 0.01	1.00E00
organic cation transport (GO:0015695)	6	0	.07	-	 < 0.01	1.00E00
defense response to virus (GO:0051607)	3	0	.04	-	 < 0.01	1.00E00
response to bacterium (GO:0009617)	14	0	.17	-	 < 0.01	1.00E00
positive regulation of canonical Wnt signaling pathway (GO:0090263)	20	0	.24	-	 < 0.01	1.00E00
detection of stimulus (GO:0051606)	23	0	.28	-	 < 0.01	1.00E00
response to virus (GO:0009615)	3	0	.04	-	 < 0.01	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	13	0	.16	-	 < 0.01	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of synapse assembly (GO:0051965)	9	0	.11	-	 < 0.01	1.00E00
DNA-templated transcription elongation (GO:0006354)	11	0	.13	-	 < 0.01	1.00E00
response to mechanical stimulus (GO:0009612)	8	0	.10	-	 < 0.01	1.00E00
positive regulation of nervous system development (GO:0051962)	25	0	.30	-	 < 0.01	1.00E00
DNA-templated transcription initiation (GO:0006352)	32	0	.39	-	 < 0.01	1.00E00
DNA-templated transcription (GO:0006351)	75	0	.90	-	 < 0.01	1.00E00
regulation of nervous system development (GO:0051960)	42	0	.51	-	 < 0.01	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	16	0	.19	-	 < 0.01	1.00E00
sodium ion homeostasis (GO:0055078)	11	0	.13	-	 < 0.01	1.00E00
nervous system process (GO:0050877)	56	0	.68	-	 < 0.01	1.00E00
regulation of apoptotic process (GO:0042981)	90	0	1.09	-	 < 0.01	6.30E-01
calcium ion homeostasis (GO:0055074)	58	0	.70	-	 < 0.01	1.00E00
positive regulation of secretion by cell (GO:1903532)	6	0	.07	-	 < 0.01	1.00E00
positive regulation of T cell activation (GO:0050870)	3	0	.04	-	 < 0.01	1.00E00
regulation of muscle system process (GO:0090257)	9	0	.11	-	 < 0.01	1.00E00
response to biotic stimulus (GO:0009607)	40	0	.48	-	 < 0.01	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	28	0	.34	-	 < 0.01	1.00E00
negative regulation of signal transduction (GO:0009968)	148	0	1.79	-	 < 0.01	4.29E-01
nucleosome organization (GO:0034728)	11	0	.13	-	 < 0.01	1.00E00
positive regulation of signal transduction (GO:0009967)	162	0	1.95	-	 < 0.01	2.70E-01
piecemeal microautophagy of the nucleus (GO:0034727)	16	0	.19	-	 < 0.01	1.00E00
regulation of signal transduction (GO:0009966)	432	0	5.21	-	 < 0.01	1.07E-02
negative regulation of T cell activation (GO:0050868)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of cell activation (GO:0050867)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of cell activation (GO:0050866)	6	0	.07	-	 < 0.01	1.00E00
regulation of cell activation (GO:0050865)	13	0	.16	-	 < 0.01	1.00E00
regulation of T cell activation (GO:0050863)	6	0	.07	-	 < 0.01	1.00E00
response to lipid (GO:0033993)	32	0	.39	-	 < 0.01	1.00E00
adenosine metabolic process (GO:0046085)	4	0	.05	-	 < 0.01	1.00E00
establishment of cell polarity (GO:0030010)	22	0	.27	-	 < 0.01	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	6	0	.07	-	 < 0.01	1.00E00
sensory organ development (GO:0007423)	42	0	.51	-	 < 0.01	1.00E00
peripheral nervous system development (GO:0007422)	1	0	.01	-	 < 0.01	1.00E00
brain development (GO:0007420)	45	0	.54	-	 < 0.01	1.00E00
mitochondrial translation (GO:0032543)	12	0	.14	-	 < 0.01	1.00E00
mRNA stabilization (GO:0048255)	11	0	.13	-	 < 0.01	1.00E00
nucleosome assembly (GO:0006334)	9	0	.11	-	 < 0.01	1.00E00
cholesterol biosynthetic process (GO:0006695)	7	0	.08	-	 < 0.01	1.00E00
steroid biosynthetic process (GO:0006694)	15	0	.18	-	 < 0.01	1.00E00
anterior/posterior pattern specification (GO:0009952)	29	0	.35	-	 < 0.01	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	8	0	.10	-	 < 0.01	1.00E00
prostaglandin metabolic process (GO:0006693)	3	0	.04	-	 < 0.01	1.00E00
regulation of vasculature development (GO:1901342)	21	0	.25	-	 < 0.01	1.00E00
icosanoid metabolic process (GO:0006690)	8	0	.10	-	 < 0.01	1.00E00
cell adhesion mediated by integrin (GO:0033627)	19	0	.23	-	 < 0.01	1.00E00
B cell receptor signaling pathway (GO:0050853)	9	0	.11	-	 < 0.01	1.00E00
T cell receptor signaling pathway (GO:0050852)	17	0	.21	-	 < 0.01	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	22	0	.27	-	 < 0.01	1.00E00
lytic vacuole organization (GO:0080171)	14	0	.17	-	 < 0.01	1.00E00
central nervous system development (GO:0007417)	73	0	.88	-	 < 0.01	1.00E00
synapse assembly (GO:0007416)	20	0	.24	-	 < 0.01	1.00E00
regulation of cellular component size (GO:0032535)	53	0	.64	-	 < 0.01	1.00E00
axon guidance (GO:0007411)	99	0	1.19	-	 < 0.01	6.35E-01
macrophage chemotaxis (GO:0048246)	1	0	.01	-	 < 0.01	1.00E00
sensory organ morphogenesis (GO:0090596)	7	0	.08	-	 < 0.01	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	11	0	.13	-	 < 0.01	1.00E00
cellular response to nitrogen compound (GO:1901699)	63	0	.76	-	 < 0.01	1.00E00
sperm capacitation (GO:0048240)	1	0	.01	-	 < 0.01	1.00E00
response to nitrogen compound (GO:1901698)	100	0	1.21	-	 < 0.01	6.36E-01
positive regulation of establishment of protein localization (GO:1904951)	5	0	.06	-	 < 0.01	1.00E00
liposaccharide metabolic process (GO:1903509)	35	0	.42	-	 < 0.01	1.00E00
membrane protein proteolysis (GO:0033619)	14	0	.17	-	 < 0.01	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.04	-	 < 0.01	1.00E00
axonogenesis (GO:0007409)	115	0	1.39	-	 < 0.01	6.51E-01
protein localization to cell junction (GO:1902414)	17	0	.21	-	 < 0.01	1.00E00
regulation of microtubule-based process (GO:0032886)	41	0	.49	-	 < 0.01	1.00E00
embryonic morphogenesis (GO:0048598)	33	0	.40	-	 < 0.01	1.00E00
mitotic cytokinetic process (GO:1902410)	2	0	.02	-	 < 0.01	1.00E00
male gamete generation (GO:0048232)	17	0	.21	-	 < 0.01	1.00E00
camera-type eye morphogenesis (GO:0048593)	4	0	.05	-	 < 0.01	1.00E00
eye morphogenesis (GO:0048592)	5	0	.06	-	 < 0.01	1.00E00
regulation of calcium ion transport (GO:0051924)	18	0	.22	-	 < 0.01	1.00E00
mitotic recombination (GO:0006312)	6	0	.07	-	 < 0.01	1.00E00
ceramide metabolic process (GO:0006672)	34	0	.41	-	 < 0.01	1.00E00
DNA recombination (GO:0006310)	76	0	.92	-	 < 0.01	1.00E00
P-body assembly (GO:0033962)	8	0	.10	-	 < 0.01	1.00E00
developmental growth (GO:0048589)	7	0	.08	-	 < 0.01	1.00E00
developmental cell growth (GO:0048588)	5	0	.06	-	 < 0.01	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	16	0	.19	-	 < 0.01	1.00E00
DNA catabolic process (GO:0006308)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of response to stimulus (GO:0048584)	226	0	2.73	-	 < 0.01	1.18E-01
cellular response to hormone stimulus (GO:0032870)	58	0	.70	-	 < 0.01	1.00E00
sphingolipid metabolic process (GO:0006665)	50	0	.60	-	 < 0.01	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	16	0	.19	-	 < 0.01	1.00E00
glycolipid metabolic process (GO:0006664)	34	0	.41	-	 < 0.01	1.00E00
double-strand break repair (GO:0006302)	91	0	1.10	-	 < 0.01	6.30E-01
postreplication repair (GO:0006301)	14	0	.17	-	 < 0.01	1.00E00
dipeptide transport (GO:0042938)	2	0	.02	-	 < 0.01	1.00E00
vesicle transport along microtubule (GO:0047496)	16	0	.19	-	 < 0.01	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of cell migration (GO:0030336)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of cell migration (GO:0030335)	44	0	.53	-	 < 0.01	1.00E00
regulation of cell migration (GO:0030334)	86	0	1.04	-	 < 0.01	6.29E-01
protein stabilization (GO:0050821)	12	0	.14	-	 < 0.01	1.00E00
microtubule-based transport (GO:0099111)	52	0	.63	-	 < 0.01	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	21	0	.25	-	 < 0.01	1.00E00
DNA duplex unwinding (GO:0032508)	12	0	.14	-	 < 0.01	1.00E00
cellular response to insulin stimulus (GO:0032869)	16	0	.19	-	 < 0.01	1.00E00
cytokinetic process (GO:0032506)	9	0	.11	-	 < 0.01	1.00E00
response to insulin (GO:0032868)	16	0	.19	-	 < 0.01	1.00E00
IMP metabolic process (GO:0046040)	9	0	.11	-	 < 0.01	1.00E00
multicellular organism reproduction (GO:0032504)	28	0	.34	-	 < 0.01	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	15	0	.18	-	 < 0.01	1.00E00
hormone transport (GO:0009914)	3	0	.04	-	 < 0.01	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	2	0	.02	-	 < 0.01	1.00E00
epidermal cell differentiation (GO:0009913)	2	0	.02	-	 < 0.01	1.00E00
regulation of cellular response to stress (GO:0080135)	30	0	.36	-	 < 0.01	1.00E00
ATP metabolic process (GO:0046034)	16	0	.19	-	 < 0.01	1.00E00
carboxylic acid catabolic process (GO:0046395)	68	0	.82	-	 < 0.01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	53	0	.64	-	 < 0.01	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	21	0	.25	-	 < 0.01	1.00E00
embryonic organ development (GO:0048568)	21	0	.25	-	 < 0.01	1.00E00
glycosyl compound catabolic process (GO:1901658)	13	0	.16	-	 < 0.01	1.00E00
glycosyl compound metabolic process (GO:1901657)	23	0	.28	-	 < 0.01	1.00E00
membrane lipid metabolic process (GO:0006643)	68	0	.82	-	 < 0.01	1.00E00
triglyceride metabolic process (GO:0006641)	15	0	.18	-	 < 0.01	1.00E00
cellular response to peptide (GO:1901653)	22	0	.27	-	 < 0.01	1.00E00
positive regulation of protein modification process (GO:0031401)	71	0	.86	-	 < 0.01	1.00E00
response to peptide (GO:1901652)	24	0	.29	-	 < 0.01	1.00E00
negative regulation of protein modification process (GO:0031400)	41	0	.49	-	 < 0.01	1.00E00
cardiac muscle cell differentiation (GO:0055007)	6	0	.07	-	 < 0.01	1.00E00
regulation of synapse organization (GO:0050807)	16	0	.19	-	 < 0.01	1.00E00
positive regulation of protein localization (GO:1903829)	11	0	.13	-	 < 0.01	1.00E00
positive regulation of synaptic transmission (GO:0050806)	20	0	.24	-	 < 0.01	1.00E00
melanocyte differentiation (GO:0030318)	1	0	.01	-	 < 0.01	1.00E00
modulation of chemical synaptic transmission (GO:0050804)	77	0	.93	-	 < 0.01	1.00E00
flagellated sperm motility (GO:0030317)	1	0	.01	-	 < 0.01	1.00E00
striated muscle cell development (GO:0055002)	22	0	.27	-	 < 0.01	1.00E00
regulation of synapse structure or activity (GO:0050803)	17	0	.21	-	 < 0.01	1.00E00
osteoclast differentiation (GO:0030316)	3	0	.04	-	 < 0.01	1.00E00
muscle cell development (GO:0055001)	31	0	.37	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	3	0	.04	-	 < 0.01	1.00E00
acylglycerol metabolic process (GO:0006639)	21	0	.25	-	 < 0.01	1.00E00
neutral lipid metabolic process (GO:0006638)	21	0	.25	-	 < 0.01	1.00E00
acyl-CoA metabolic process (GO:0006637)	17	0	.21	-	 < 0.01	1.00E00
nuclear envelope organization (GO:0006998)	9	0	.11	-	 < 0.01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	4	0	.05	-	 < 0.01	1.00E00
fatty acid beta-oxidation (GO:0006635)	21	0	.25	-	 < 0.01	1.00E00
nucleus organization (GO:0006997)	14	0	.17	-	 < 0.01	1.00E00
heart process (GO:0003015)	18	0	.22	-	 < 0.01	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	4	0	.05	-	 < 0.01	1.00E00
fatty acid biosynthetic process (GO:0006633)	25	0	.30	-	 < 0.01	1.00E00
circulatory system process (GO:0003013)	38	0	.46	-	 < 0.01	1.00E00
muscle system process (GO:0003012)	27	0	.33	-	 < 0.01	1.00E00
chaperone-mediated protein folding (GO:0061077)	12	0	.14	-	 < 0.01	1.00E00
fatty acid metabolic process (GO:0006631)	76	0	.92	-	 < 0.01	1.00E00
reproductive process (GO:0022414)	74	0	.89	-	 < 0.01	1.00E00
ERBB signaling pathway (GO:0038127)	12	0	.14	-	 < 0.01	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	23	0	.28	-	 < 0.01	1.00E00
T cell activation involved in immune response (GO:0002286)	2	0	.02	-	 < 0.01	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	2	0	.02	-	 < 0.01	1.00E00
DNA demethylation (GO:0080111)	5	0	.06	-	 < 0.01	1.00E00
cholesterol transport (GO:0030301)	10	0	.12	-	 < 0.01	1.00E00
macrophage activation involved in immune response (GO:0002281)	1	0	.01	-	 < 0.01	1.00E00
cellular response to endogenous stimulus (GO:0071495)	154	0	1.86	-	 < 0.01	2.68E-01
positive regulation of cation channel activity (GO:2001259)	4	0	.05	-	 < 0.01	1.00E00
response to steroid hormone (GO:0048545)	8	0	.10	-	 < 0.01	1.00E00
skeletal muscle contraction (GO:0003009)	7	0	.08	-	 < 0.01	1.00E00
system process (GO:0003008)	99	0	1.19	-	 < 0.01	6.35E-01
negative regulation of chromosome organization (GO:2001251)	10	0	.12	-	 < 0.01	1.00E00
transforming growth factor beta receptor superfamily signaling pathway (GO:0141091)	30	0	.36	-	 < 0.01	1.00E00
heart morphogenesis (GO:0003007)	11	0	.13	-	 < 0.01	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	1	0	.01	-	 < 0.01	1.00E00
protein targeting to mitochondrion (GO:0006626)	19	0	.23	-	 < 0.01	1.00E00
developmental process involved in reproduction (GO:0003006)	25	0	.30	-	 < 0.01	1.00E00
response to unfolded protein (GO:0006986)	19	0	.23	-	 < 0.01	1.00E00
protein targeting to lysosome (GO:0006622)	2	0	.02	-	 < 0.01	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of mitotic cell cycle phase transition (GO:1901991)	28	0	.34	-	 < 0.01	1.00E00
regulation of mitotic cell cycle phase transition (GO:1901990)	51	0	.62	-	 < 0.01	1.00E00
cell cycle process (GO:0022402)	215	0	2.59	-	 < 0.01	1.18E-01
myeloid leukocyte activation (GO:0002274)	2	0	.02	-	 < 0.01	1.00E00
visual system development (GO:0150063)	28	0	.34	-	 < 0.01	1.00E00
cellular response to light stimulus (GO:0071482)	8	0	.10	-	 < 0.01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	4	0	.05	-	 < 0.01	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	7	0	.08	-	 < 0.01	1.00E00
response to oxidative stress (GO:0006979)	22	0	.27	-	 < 0.01	1.00E00
negative regulation of cell cycle phase transition (GO:1901988)	44	0	.53	-	 < 0.01	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	7	0	.08	-	 < 0.01	1.00E00
interstrand cross-link repair (GO:0036297)	11	0	.13	-	 < 0.01	1.00E00
regulation of cell cycle phase transition (GO:1901987)	72	0	.87	-	 < 0.01	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	7	0	.08	-	 < 0.01	1.00E00
protein export from nucleus (GO:0006611)	10	0	.12	-	 < 0.01	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	2	0	.02	-	 < 0.01	1.00E00
response to osmotic stress (GO:0006970)	3	0	.04	-	 < 0.01	1.00E00
cell activation involved in immune response (GO:0002263)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	4	0	.05	-	 < 0.01	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	11	0	.13	-	 < 0.01	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	15	0	.18	-	 < 0.01	1.00E00
positive regulation of apoptotic signaling pathway (GO:2001235)	8	0	.10	-	 < 0.01	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	16	0	.19	-	 < 0.01	1.00E00
regulation of apoptotic signaling pathway (GO:2001233)	24	0	.29	-	 < 0.01	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	10	0	.12	-	 < 0.01	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	41	0	.49	-	 < 0.01	1.00E00
sensory system development (GO:0048880)	28	0	.34	-	 < 0.01	1.00E00
positive regulation of cell motility (GO:2000147)	47	0	.57	-	 < 0.01	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of cell motility (GO:2000146)	10	0	.12	-	 < 0.01	1.00E00
regulation of cell motility (GO:2000145)	89	0	1.07	-	 < 0.01	6.30E-01
cilium movement (GO:0003341)	18	0	.22	-	 < 0.01	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	17	0	.21	-	 < 0.01	1.00E00
miRNA processing (GO:0035196)	11	0	.13	-	 < 0.01	1.00E00
amino sugar catabolic process (GO:0046348)	3	0	.04	-	 < 0.01	1.00E00
activation of immune response (GO:0002253)	40	0	.48	-	 < 0.01	1.00E00
protein K48-linked deubiquitination (GO:0071108)	3	0	.04	-	 < 0.01	1.00E00
immune effector process (GO:0002252)	9	0	.11	-	 < 0.01	1.00E00
regulatory ncRNA-mediated post-transcriptional gene silencing (GO:0035194)	9	0	.11	-	 < 0.01	1.00E00
regulation of GTPase activity (GO:0043087)	66	0	.80	-	 < 0.01	1.00E00
negative regulation of catalytic activity (GO:0043086)	58	0	.70	-	 < 0.01	1.00E00
adaptive immune response (GO:0002250)	8	0	.10	-	 < 0.01	1.00E00
DNA conformation change (GO:0071103)	15	0	.18	-	 < 0.01	1.00E00
spermatid differentiation (GO:0048515)	4	0	.05	-	 < 0.01	1.00E00
blood vessel morphogenesis (GO:0048514)	34	0	.41	-	 < 0.01	1.00E00
humoral immune response (GO:0006959)	7	0	.08	-	 < 0.01	1.00E00
nucleobase-containing compound transport (GO:0015931)	53	0	.64	-	 < 0.01	1.00E00
rhythmic process (GO:0048511)	22	0	.27	-	 < 0.01	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	23	0	.28	-	 < 0.01	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	23	0	.28	-	 < 0.01	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	12	0	.14	-	 < 0.01	1.00E00
multicellular organismal-level homeostasis (GO:0048871)	11	0	.13	-	 < 0.01	1.00E00
complement activation (GO:0006956)	4	0	.05	-	 < 0.01	1.00E00
immune response (GO:0006955)	53	0	.64	-	 < 0.01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	72	0	.87	-	 < 0.01	1.00E00
DNA damage checkpoint signaling (GO:0000077)	19	0	.23	-	 < 0.01	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	16	0	.19	-	 < 0.01	1.00E00
DNA replication checkpoint signaling (GO:0000076)	7	0	.08	-	 < 0.01	1.00E00
inflammatory response (GO:0006954)	19	0	.23	-	 < 0.01	1.00E00
cell cycle checkpoint signaling (GO:0000075)	35	0	.42	-	 < 0.01	1.00E00
defense response (GO:0006952)	53	0	.64	-	 < 0.01	1.00E00
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	6	0	.07	-	 < 0.01	1.00E00
mitotic sister chromatid segregation (GO:0000070)	34	0	.41	-	 < 0.01	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of JNK cascade (GO:0046330)	8	0	.10	-	 < 0.01	1.00E00
syncytium formation (GO:0006949)	3	0	.04	-	 < 0.01	1.00E00
striated muscle contraction (GO:0006941)	18	0	.22	-	 < 0.01	1.00E00
response to molecule of bacterial origin (GO:0002237)	12	0	.14	-	 < 0.01	1.00E00
regulation of JNK cascade (GO:0046328)	11	0	.13	-	 < 0.01	1.00E00
positive regulation of programmed cell death (GO:0043068)	32	0	.39	-	 < 0.01	1.00E00
negative regulation of apoptotic process (GO:0043066)	47	0	.57	-	 < 0.01	1.00E00
positive regulation of apoptotic process (GO:0043065)	31	0	.37	-	 < 0.01	1.00E00
cilium movement involved in cell motility (GO:0060294)	10	0	.12	-	 < 0.01	1.00E00
sterol transport (GO:0015918)	15	0	.18	-	 < 0.01	1.00E00
phospholipid transport (GO:0015914)	30	0	.36	-	 < 0.01	1.00E00
positive regulation of cell differentiation (GO:0045597)	47	0	.57	-	 < 0.01	1.00E00
regulation of cell differentiation (GO:0045595)	86	0	1.04	-	 < 0.01	6.29E-01
inorganic anion transmembrane transport (GO:0098661)	37	0	.45	-	 < 0.01	1.00E00
regulation of muscle contraction (GO:0006937)	7	0	.08	-	 < 0.01	1.00E00
muscle contraction (GO:0006936)	26	0	.31	-	 < 0.01	1.00E00
chemotaxis (GO:0006935)	33	0	.40	-	 < 0.01	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	3	0	.04	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	20	0	.24	-	 < 0.01	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	8	0	.10	-	 < 0.01	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	28	0	.34	-	 < 0.01	1.00E00
purine-containing compound catabolic process (GO:0072523)	22	0	.27	-	 < 0.01	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	18	0	.22	-	 < 0.01	1.00E00
toll-like receptor signaling pathway (GO:0002224)	4	0	.05	-	 < 0.01	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	11	0	.13	-	 < 0.01	1.00E00
cilium-dependent cell motility (GO:0060285)	12	0	.14	-	 < 0.01	1.00E00
regulation of cell development (GO:0060284)	46	0	.55	-	 < 0.01	1.00E00
long-chain fatty acid transport (GO:0015909)	3	0	.04	-	 < 0.01	1.00E00
fatty acid transport (GO:0015908)	18	0	.22	-	 < 0.01	1.00E00
monoatomic anion transmembrane transport (GO:0098656)	37	0	.45	-	 < 0.01	1.00E00
transition metal ion transport (GO:0000041)	31	0	.37	-	 < 0.01	1.00E00
activation of innate immune response (GO:0002218)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of peptidase activity (GO:0010466)	22	0	.27	-	 < 0.01	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	9	0	.11	-	 < 0.01	1.00E00
centrosome duplication (GO:0051298)	10	0	.12	-	 < 0.01	1.00E00
male sex differentiation (GO:0046661)	1	0	.01	-	 < 0.01	1.00E00
protein localization to Golgi apparatus (GO:0034067)	9	0	.11	-	 < 0.01	1.00E00
inner ear development (GO:0048839)	2	0	.02	-	 < 0.01	1.00E00
establishment of spindle orientation (GO:0051294)	10	0	.12	-	 < 0.01	1.00E00
cell-cell junction organization (GO:0045216)	38	0	.46	-	 < 0.01	1.00E00
establishment of spindle localization (GO:0051293)	17	0	.21	-	 < 0.01	1.00E00
sarcomere organization (GO:0045214)	15	0	.18	-	 < 0.01	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	12	0	.14	-	 < 0.01	1.00E00
apoptotic process (GO:0006915)	53	0	.64	-	 < 0.01	1.00E00
phagocytosis, engulfment (GO:0006911)	5	0	.06	-	 < 0.01	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	27	0	.33	-	 < 0.01	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	10	0	.12	-	 < 0.01	1.00E00
cellular response to organonitrogen compound (GO:0071417)	43	0	.52	-	 < 0.01	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	2	0	.02	-	 < 0.01	1.00E00
somatic diversification of immune receptors (GO:0002200)	2	0	.02	-	 < 0.01	1.00E00
response to fibroblast growth factor (GO:0071774)	24	0	.29	-	 < 0.01	1.00E00
regulation of macrophage activation (GO:0043030)	1	0	.01	-	 < 0.01	1.00E00
cellular response to BMP stimulus (GO:0071773)	15	0	.18	-	 < 0.01	1.00E00
response to BMP (GO:0071772)	15	0	.18	-	 < 0.01	1.00E00
triglyceride homeostasis (GO:0070328)	5	0	.06	-	 < 0.01	1.00E00
phagocytosis (GO:0006909)	17	0	.21	-	 < 0.01	1.00E00
ribosomal large subunit assembly (GO:0000027)	8	0	.10	-	 < 0.01	1.00E00
spliceosomal snRNP assembly (GO:0000387)	13	0	.16	-	 < 0.01	1.00E00
vesicle targeting (GO:0006903)	6	0	.07	-	 < 0.01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	6	0	.07	-	 < 0.01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	23	0	.28	-	 < 0.01	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	4	0	.05	-	 < 0.01	1.00E00
nuclear membrane organization (GO:0071763)	4	0	.05	-	 < 0.01	1.00E00
central nervous system neuron differentiation (GO:0021953)	6	0	.07	-	 < 0.01	1.00E00
dendrite morphogenesis (GO:0048813)	2	0	.02	-	 < 0.01	1.00E00
regulation of DNA recombination (GO:0000018)	6	0	.07	-	 < 0.01	1.00E00
granulocyte migration (GO:0097530)	3	0	.04	-	 < 0.01	1.00E00
anatomical structure homeostasis (GO:0060249)	4	0	.05	-	 < 0.01	1.00E00
camera-type eye development (GO:0043010)	22	0	.27	-	 < 0.01	1.00E00
telomere localization (GO:0034397)	1	0	.01	-	 < 0.01	1.00E00
protein depolymerization (GO:0051261)	22	0	.27	-	 < 0.01	1.00E00
myeloid leukocyte migration (GO:0097529)	3	0	.04	-	 < 0.01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	5	0	.06	-	 < 0.01	1.00E00
synaptic vesicle exocytosis (GO:0016079)	20	0	.24	-	 < 0.01	1.00E00
reproduction (GO:0000003)	74	0	.89	-	 < 0.01	1.00E00
motile cilium assembly (GO:0044458)	4	0	.05	-	 < 0.01	1.00E00
mitochondrial genome maintenance (GO:0000002)	6	0	.07	-	 < 0.01	1.00E00
snRNA metabolic process (GO:0016073)	24	0	.29	-	 < 0.01	1.00E00
rRNA metabolic process (GO:0016072)	89	0	1.07	-	 < 0.01	6.30E-01
centriole replication (GO:0007099)	9	0	.11	-	 < 0.01	1.00E00
centrosome cycle (GO:0007098)	17	0	.21	-	 < 0.01	1.00E00
nuclear migration (GO:0007097)	10	0	.12	-	 < 0.01	1.00E00
negative regulation of double-strand break repair (GO:2000780)	5	0	.06	-	 < 0.01	1.00E00
chordate embryonic development (GO:0043009)	17	0	.21	-	 < 0.01	1.00E00
mitotic G2 DNA damage checkpoint signaling (GO:0007095)	8	0	.10	-	 < 0.01	1.00E00
mitotic spindle assembly checkpoint signaling (GO:0007094)	9	0	.11	-	 < 0.01	1.00E00
regulation of mitotic spindle organization (GO:0060236)	2	0	.02	-	 < 0.01	1.00E00
mitotic cell cycle checkpoint signaling (GO:0007093)	24	0	.29	-	 < 0.01	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	2	0	.02	-	 < 0.01	1.00E00
protein polymerization (GO:0051258)	29	0	.35	-	 < 0.01	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	7	0	.08	-	 < 0.01	1.00E00
response to temperature stimulus (GO:0009266)	12	0	.14	-	 < 0.01	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	8	0	.10	-	 < 0.01	1.00E00
calcium-ion regulated exocytosis (GO:0017156)	15	0	.18	-	 < 0.01	1.00E00
ribonucleotide catabolic process (GO:0009261)	18	0	.22	-	 < 0.01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	5	0	.06	-	 < 0.01	1.00E00
purine nucleoside metabolic process (GO:0042278)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	5	0	.06	-	 < 0.01	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	42	0	.51	-	 < 0.01	1.00E00
regulation of double-strand break repair (GO:2000779)	7	0	.08	-	 < 0.01	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	4	0	.05	-	 < 0.01	1.00E00
cell-cell fusion (GO:0140253)	3	0	.04	-	 < 0.01	1.00E00
immunoglobulin mediated immune response (GO:0016064)	2	0	.02	-	 < 0.01	1.00E00
regulation of mitotic nuclear division (GO:0007088)	22	0	.27	-	 < 0.01	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	15	0	.18	-	 < 0.01	1.00E00
immune system development (GO:0002520)	5	0	.06	-	 < 0.01	1.00E00
forebrain development (GO:0030900)	11	0	.13	-	 < 0.01	1.00E00
regulation of lymphocyte activation (GO:0051249)	10	0	.12	-	 < 0.01	1.00E00
mitotic metaphase chromosome alignment (GO:0007080)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of protein metabolic process (GO:0051248)	86	0	1.04	-	 < 0.01	6.29E-01
positive regulation of protein metabolic process (GO:0051247)	130	0	1.57	-	 < 0.01	4.12E-01
regulation of protein metabolic process (GO:0051246)	263	0	3.17	-	 < 0.01	7.96E-02
negative regulation of translation (GO:0017148)	14	0	.17	-	 < 0.01	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	2	0	.02	-	 < 0.01	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	6	0	.07	-	 < 0.01	1.00E00
protein modification by small protein removal (GO:0070646)	63	0	.76	-	 < 0.01	1.00E00
hexose biosynthetic process (GO:0019319)	7	0	.08	-	 < 0.01	1.00E00
hexose metabolic process (GO:0019318)	20	0	.24	-	 < 0.01	1.00E00
Wnt signaling pathway (GO:0016055)	53	0	.64	-	 < 0.01	1.00E00
organic acid catabolic process (GO:0016054)	68	0	.82	-	 < 0.01	1.00E00
mannosylation (GO:0097502)	8	0	.10	-	 < 0.01	1.00E00
organic acid biosynthetic process (GO:0016053)	53	0	.64	-	 < 0.01	1.00E00
regulation of lymphocyte migration (GO:2000401)	3	0	.04	-	 < 0.01	1.00E00
carbohydrate catabolic process (GO:0016052)	26	0	.31	-	 < 0.01	1.00E00
mitotic chromosome condensation (GO:0007076)	6	0	.07	-	 < 0.01	1.00E00
regulation of centrosome cycle (GO:0046605)	6	0	.07	-	 < 0.01	1.00E00
glycolipid biosynthetic process (GO:0009247)	27	0	.33	-	 < 0.01	1.00E00
establishment of RNA localization (GO:0051236)	35	0	.42	-	 < 0.01	1.00E00
maintenance of location (GO:0051235)	25	0	.30	-	 < 0.01	1.00E00
spindle elongation (GO:0051231)	6	0	.07	-	 < 0.01	1.00E00
cell growth (GO:0016049)	5	0	.06	-	 < 0.01	1.00E00
actin polymerization or depolymerization (GO:0008154)	29	0	.35	-	 < 0.01	1.00E00
cell cycle DNA replication (GO:0044786)	12	0	.14	-	 < 0.01	1.00E00
lipid catabolic process (GO:0016042)	66	0	.80	-	 < 0.01	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	2	0	.02	-	 < 0.01	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	6	0	.07	-	 < 0.01	1.00E00
sister chromatid cohesion (GO:0007062)	14	0	.17	-	 < 0.01	1.00E00
septin cytoskeleton organization (GO:0032185)	2	0	.02	-	 < 0.01	1.00E00
peptidyl-tyrosine modification (GO:0018212)	8	0	.10	-	 < 0.01	1.00E00
spindle assembly (GO:0051225)	22	0	.27	-	 < 0.01	1.00E00
developmental growth involved in morphogenesis (GO:0060560)	5	0	.06	-	 < 0.01	1.00E00
regeneration (GO:0031099)	2	0	.02	-	 < 0.01	1.00E00
regulation of protein transport (GO:0051223)	11	0	.13	-	 < 0.01	1.00E00
positive regulation of protein transport (GO:0051222)	3	0	.04	-	 < 0.01	1.00E00
detection of chemical stimulus (GO:0009593)	5	0	.06	-	 < 0.01	1.00E00
tissue regeneration (GO:0042246)	2	0	.02	-	 < 0.01	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	5	0	.06	-	 < 0.01	1.00E00
positive regulation of proteolysis (GO:0045862)	38	0	.46	-	 < 0.01	1.00E00
negative regulation of proteolysis (GO:0045861)	27	0	.33	-	 < 0.01	1.00E00
biological process involved in interspecies interaction between organisms (GO:0044419)	40	0	.48	-	 < 0.01	1.00E00
positive regulation of protein kinase activity (GO:0045860)	27	0	.33	-	 < 0.01	1.00E00
chromosome segregation (GO:0007059)	76	0	.92	-	 < 0.01	1.00E00
nuclear DNA replication (GO:0033260)	12	0	.14	-	 < 0.01	1.00E00
mitotic DNA integrity checkpoint signaling (GO:0044774)	13	0	.16	-	 < 0.01	1.00E00
cytoskeleton-dependent cytokinesis (GO:0061640)	27	0	.33	-	 < 0.01	1.00E00
mitotic DNA damage checkpoint signaling (GO:0044773)	13	0	.16	-	 < 0.01	1.00E00
mitotic cell cycle phase transition (GO:0044772)	33	0	.40	-	 < 0.01	1.00E00
cell cycle phase transition (GO:0044770)	33	0	.40	-	 < 0.01	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.06	-	 < 0.01	1.00E00
membrane assembly (GO:0071709)	11	0	.13	-	 < 0.01	1.00E00
mitotic spindle organization (GO:0007052)	25	0	.30	-	 < 0.01	1.00E00
spindle organization (GO:0007051)	38	0	.46	-	 < 0.01	1.00E00
cartilage development (GO:0051216)	10	0	.12	-	 < 0.01	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	7	0	.08	-	 < 0.01	1.00E00
regulation of protein kinase activity (GO:0045859)	79	0	.95	-	 < 0.01	1.00E00
neuron migration (GO:0001764)	9	0	.11	-	 < 0.01	1.00E00
morphogenesis of a branching structure (GO:0001763)	1	0	.01	-	 < 0.01	1.00E00
protein K11-linked ubiquitination (GO:0070979)	7	0	.08	-	 < 0.01	1.00E00
glucose homeostasis (GO:0042593)	7	0	.08	-	 < 0.01	1.00E00
aerobic electron transport chain (GO:0019646)	4	0	.05	-	 < 0.01	1.00E00
cell cycle (GO:0007049)	239	0	2.88	-	 < 0.01	1.23E-01
cell-substrate junction assembly (GO:0007044)	1	0	.01	-	 < 0.01	1.00E00
cell-cell junction assembly (GO:0007043)	32	0	.39	-	 < 0.01	1.00E00
lysosomal transport (GO:0007041)	19	0	.23	-	 < 0.01	1.00E00
lysosome organization (GO:0007040)	14	0	.17	-	 < 0.01	1.00E00
protein insertion into membrane (GO:0051205)	4	0	.05	-	 < 0.01	1.00E00
adherens junction organization (GO:0034332)	20	0	.24	-	 < 0.01	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	10	0	.12	-	 < 0.01	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	9	0	.11	-	 < 0.01	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	7	0	.08	-	 < 0.01	1.00E00
ERAD pathway (GO:0036503)	34	0	.41	-	 < 0.01	1.00E00
response to reactive oxygen species (GO:0000302)	7	0	.08	-	 < 0.01	1.00E00
meiosis I cell cycle process (GO:0061982)	27	0	.33	-	 < 0.01	1.00E00
protein localization to synapse (GO:0035418)	13	0	.16	-	 < 0.01	1.00E00
skeletal muscle organ development (GO:0060538)	15	0	.18	-	 < 0.01	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	14	0	.17	-	 < 0.01	1.00E00
muscle tissue development (GO:0060537)	28	0	.34	-	 < 0.01	1.00E00
endosome organization (GO:0007032)	13	0	.16	-	 < 0.01	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	20	0	.24	-	 < 0.01	1.00E00
peroxisome organization (GO:0007031)	20	0	.24	-	 < 0.01	1.00E00
Golgi organization (GO:0007030)	40	0	.48	-	 < 0.01	1.00E00
regulation of response to biotic stimulus (GO:0002831)	25	0	.30	-	 < 0.01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	4	0	.05	-	 < 0.01	1.00E00
cell junction assembly (GO:0034329)	52	0	.63	-	 < 0.01	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	1	0	.01	-	 < 0.01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	17	0	.21	-	 < 0.01	1.00E00
positive regulation of cell development (GO:0010720)	28	0	.34	-	 < 0.01	1.00E00
fertilization (GO:0009566)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	9	0	.11	-	 < 0.01	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	3	0	.04	-	 < 0.01	1.00E00
translesion synthesis (GO:0019985)	10	0	.12	-	 < 0.01	1.00E00
endoplasmic reticulum organization (GO:0007029)	21	0	.25	-	 < 0.01	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	22	0	.27	-	 < 0.01	1.00E00
activation of protein kinase activity (GO:0032147)	5	0	.06	-	 < 0.01	1.00E00
microtubule nucleation (GO:0007020)	16	0	.19	-	 < 0.01	1.00E00
positive regulation of adaptive immune response (GO:0002821)	1	0	.01	-	 < 0.01	1.00E00
mismatch repair (GO:0006298)	10	0	.12	-	 < 0.01	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	12	0	.14	-	 < 0.01	1.00E00
pre-miRNA processing (GO:0031054)	6	0	.07	-	 < 0.01	1.00E00
primary miRNA processing (GO:0031053)	2	0	.02	-	 < 0.01	1.00E00
negative regulation of innate immune response (GO:0045824)	3	0	.04	-	 < 0.01	1.00E00
defense response to symbiont (GO:0140546)	26	0	.31	-	 < 0.01	1.00E00
dendrite development (GO:0016358)	7	0	.08	-	 < 0.01	1.00E00
microtubule depolymerization (GO:0007019)	9	0	.11	-	 < 0.01	1.00E00
microtubule-based movement (GO:0007018)	97	0	1.17	-	 < 0.01	6.34E-01
microtubule-based process (GO:0007017)	234	0	2.82	-	 < 0.01	1.21E-01
actin filament organization (GO:0007015)	117	0	1.41	-	 < 0.01	4.08E-01
dicarboxylic acid metabolic process (GO:0043648)	12	0	.14	-	 < 0.01	1.00E00
response to lipopolysaccharide (GO:0032496)	12	0	.14	-	 < 0.01	1.00E00
nucleotide-excision repair (GO:0006289)	18	0	.22	-	 < 0.01	1.00E00
membrane depolarization (GO:0051899)	18	0	.22	-	 < 0.01	1.00E00
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897)	11	0	.13	-	 < 0.01	1.00E00
regulatory ncRNA-mediated gene silencing (GO:0031047)	25	0	.30	-	 < 0.01	1.00E00
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051896)	13	0	.16	-	 < 0.01	1.00E00
base-excision repair (GO:0006284)	11	0	.13	-	 < 0.01	1.00E00
regulation of DNA repair (GO:0006282)	15	0	.18	-	 < 0.01	1.00E00
DNA repair (GO:0006281)	160	0	1.93	-	 < 0.01	2.69E-01
nucleoside phosphate catabolic process (GO:1901292)	30	0	.36	-	 < 0.01	1.00E00
protein K48-linked ubiquitination (GO:0070936)	8	0	.10	-	 < 0.01	1.00E00
myelination (GO:0042552)	12	0	.14	-	 < 0.01	1.00E00
plasma membrane organization (GO:0007009)	22	0	.27	-	 < 0.01	1.00E00
gastrulation (GO:0007369)	13	0	.16	-	 < 0.01	1.00E00
inner mitochondrial membrane organization (GO:0007007)	11	0	.13	-	 < 0.01	1.00E00
mitochondrial membrane organization (GO:0007006)	14	0	.17	-	 < 0.01	1.00E00
determination of left/right symmetry (GO:0007368)	2	0	.02	-	 < 0.01	1.00E00
regulation of cilium assembly (GO:1902017)	5	0	.06	-	 < 0.01	1.00E00
telomere maintenance via telomerase (GO:0007004)	4	0	.05	-	 < 0.01	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of locomotion (GO:0040017)	47	0	.57	-	 < 0.01	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of locomotion (GO:0040013)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of type I interferon production (GO:0032481)	2	0	.02	-	 < 0.01	1.00E00
regulation of locomotion (GO:0040012)	89	0	1.07	-	 < 0.01	6.30E-01
locomotion (GO:0040011)	33	0	.40	-	 < 0.01	1.00E00
regulation of protein modification process (GO:0031399)	140	0	1.69	-	 < 0.01	4.20E-01
negative regulation of catabolic process (GO:0009895)	33	0	.40	-	 < 0.01	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	8	0	.10	-	 < 0.01	1.00E00
positive regulation of endocytosis (GO:0045807)	2	0	.02	-	 < 0.01	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of endocytosis (GO:0045806)	4	0	.05	-	 < 0.01	1.00E00
actomyosin structure organization (GO:0031032)	46	0	.55	-	 < 0.01	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	11	0	.13	-	 < 0.01	1.00E00
DNA replication initiation (GO:0006270)	15	0	.18	-	 < 0.01	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	4	0	.05	-	 < 0.01	1.00E00
reciprocal homologous recombination (GO:0140527)	20	0	.24	-	 < 0.01	1.00E00
regulation of insulin secretion (GO:0050796)	3	0	.04	-	 < 0.01	1.00E00
regulation of developmental process (GO:0050793)	174	0	2.10	-	 < 0.01	2.78E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035)	57	0	.69	-	 < 0.01	1.00E00
sexual reproduction (GO:0019953)	71	0	.86	-	 < 0.01	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	22	0	.27	-	 < 0.01	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	12	0	.14	-	 < 0.01	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	3	0	.04	-	 < 0.01	1.00E00
regulation of growth (GO:0040008)	15	0	.18	-	 < 0.01	1.00E00
growth (GO:0040007)	7	0	.08	-	 < 0.01	1.00E00
cell fate specification (GO:0001708)	25	0	.30	-	 < 0.01	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	7	0	.08	-	 < 0.01	1.00E00
mesoderm formation (GO:0001707)	7	0	.08	-	 < 0.01	1.00E00
animal organ morphogenesis (GO:0009887)	80	0	.97	-	 < 0.01	1.00E00
endoderm formation (GO:0001706)	7	0	.08	-	 < 0.01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	13	0	.16	-	 < 0.01	1.00E00
formation of primary germ layer (GO:0001704)	13	0	.16	-	 < 0.01	1.00E00
microtubule organizing center organization (GO:0031023)	21	0	.25	-	 < 0.01	1.00E00
regulatory ncRNA processing (GO:0070918)	17	0	.21	-	 < 0.01	1.00E00
DNA-templated DNA replication (GO:0006261)	62	0	.75	-	 < 0.01	1.00E00
DNA replication (GO:0006260)	68	0	.82	-	 < 0.01	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	6	0	.07	-	 < 0.01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	7	0	.08	-	 < 0.01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	4	0	.05	-	 < 0.01	1.00E00
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.02	-	 < 0.01	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	4	0	.05	-	 < 0.01	1.00E00
sodium ion transmembrane transport (GO:0035725)	43	0	.52	-	 < 0.01	1.00E00
positive regulation of response to external stimulus (GO:0032103)	28	0	.34	-	 < 0.01	1.00E00
regulation of cytokinesis (GO:0032465)	5	0	.06	-	 < 0.01	1.00E00
intraciliary retrograde transport (GO:0035721)	6	0	.07	-	 < 0.01	1.00E00
carbohydrate derivative transport (GO:1901264)	21	0	.25	-	 < 0.01	1.00E00
amide transport (GO:0042886)	10	0	.12	-	 < 0.01	1.00E00
positive regulation of immune response (GO:0050778)	49	0	.59	-	 < 0.01	1.00E00
regulation of immune response (GO:0050776)	58	0	.70	-	 < 0.01	1.00E00
regulation of dendrite development (GO:0050773)	11	0	.13	-	 < 0.01	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	17	0	.21	-	 < 0.01	1.00E00
positive regulation of axonogenesis (GO:0050772)	6	0	.07	-	 < 0.01	1.00E00
mitochondrial RNA processing (GO:0000963)	5	0	.06	-	 < 0.01	1.00E00
regulation of TORC1 signaling (GO:1903432)	18	0	.22	-	 < 0.01	1.00E00
cGMP-mediated signaling (GO:0019934)	2	0	.02	-	 < 0.01	1.00E00
cAMP-mediated signaling (GO:0019933)	15	0	.18	-	 < 0.01	1.00E00
regulation of axonogenesis (GO:0050770)	13	0	.16	-	 < 0.01	1.00E00
binding of sperm to zona pellucida (GO:0007339)	1	0	.01	-	 < 0.01	1.00E00
dephosphorylation (GO:0016311)	88	0	1.06	-	 < 0.01	6.29E-01
bone mineralization (GO:0030282)	1	0	.01	-	 < 0.01	1.00E00
single fertilization (GO:0007338)	5	0	.06	-	 < 0.01	1.00E00
endocytic recycling (GO:0032456)	28	0	.34	-	 < 0.01	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	8	0	.10	-	 < 0.01	1.00E00
regulation of synaptic plasticity (GO:0048167)	24	0	.29	-	 < 0.01	1.00E00
cellular response to unfolded protein (GO:0034620)	19	0	.23	-	 < 0.01	1.00E00
mitochondrial protein processing (GO:0034982)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of neurogenesis (GO:0050769)	16	0	.19	-	 < 0.01	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	11	0	.13	-	 < 0.01	1.00E00
regulation of neurogenesis (GO:0050767)	30	0	.36	-	 < 0.01	1.00E00
intermembrane lipid transfer (GO:0120009)	2	0	.02	-	 < 0.01	1.00E00
regulation of canonical Wnt signaling pathway (GO:0060828)	40	0	.48	-	 < 0.01	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	2	0	.02	-	 < 0.01	1.00E00
polyamine biosynthetic process (GO:0006596)	6	0	.07	-	 < 0.01	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	58	0	.70	-	 < 0.01	1.00E00
polyamine metabolic process (GO:0006595)	7	0	.08	-	 < 0.01	1.00E00
response to tumor necrosis factor (GO:0034612)	7	0	.08	-	 < 0.01	1.00E00
lipid storage (GO:0019915)	3	0	.04	-	 < 0.01	1.00E00
chromosome condensation (GO:0030261)	6	0	.07	-	 < 0.01	1.00E00
melanosome organization (GO:0032438)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	13	0	.16	-	 < 0.01	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	4	0	.05	-	 < 0.01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	2	0	.02	-	 < 0.01	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	20	0	.24	-	 < 0.01	1.00E00
positive regulation of defense response (GO:0031349)	18	0	.22	-	 < 0.01	1.00E00
negative regulation of defense response (GO:0031348)	11	0	.13	-	 < 0.01	1.00E00
regulation of defense response (GO:0031347)	32	0	.39	-	 < 0.01	1.00E00
cellular response to heat (GO:0034605)	5	0	.06	-	 < 0.01	1.00E00
catecholamine metabolic process (GO:0006584)	5	0	.06	-	 < 0.01	1.00E00
regulation of cell projection organization (GO:0031344)	58	0	.70	-	 < 0.01	1.00E00
regulation of cell killing (GO:0031341)	2	0	.02	-	 < 0.01	1.00E00
lipid modification (GO:0030258)	60	0	.72	-	 < 0.01	1.00E00
protein-DNA complex assembly (GO:0065004)	32	0	.39	-	 < 0.01	1.00E00
biogenic amine metabolic process (GO:0006576)	17	0	.21	-	 < 0.01	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	45	0	.54	-	 < 0.01	1.00E00
negative regulation of protein-containing complex assembly (GO:0031333)	23	0	.28	-	 < 0.01	1.00E00
regulation of non-canonical NF-kappaB signal transduction (GO:1901222)	2	0	.02	-	 < 0.01	1.00E00
tyrosine metabolic process (GO:0006570)	6	0	.07	-	 < 0.01	1.00E00
negative regulation of cellular catabolic process (GO:0031330)	26	0	.31	-	 < 0.01	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	9	0	.11	-	 < 0.01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	13	0	.16	-	 < 0.01	1.00E00
non-canonical NF-kappaB signal transduction (GO:0038061)	2	0	.02	-	 < 0.01	1.00E00
carbohydrate homeostasis (GO:0033500)	7	0	.08	-	 < 0.01	1.00E00
lysosome localization (GO:0032418)	4	0	.05	-	 < 0.01	1.00E00
RNA biosynthetic process (GO:0032774)	76	0	.92	-	 < 0.01	1.00E00
regulation of monoatomic ion transmembrane transporter activity (GO:0032412)	38	0	.46	-	 < 0.01	1.00E00
positive regulation of transporter activity (GO:0032411)	11	0	.13	-	 < 0.01	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	5	0	.06	-	 < 0.01	1.00E00
negative regulation of inflammatory response (GO:0050728)	8	0	.10	-	 < 0.01	1.00E00
regulation of inflammatory response (GO:0050727)	9	0	.11	-	 < 0.01	1.00E00
myofibril assembly (GO:0030239)	22	0	.27	-	 < 0.01	1.00E00
actomyosin contractile ring assembly (GO:0000915)	3	0	.04	-	 < 0.01	1.00E00
leukocyte chemotaxis (GO:0030595)	3	0	.04	-	 < 0.01	1.00E00
cytokinesis (GO:0000910)	28	0	.34	-	 < 0.01	1.00E00
neutrophil chemotaxis (GO:0030593)	3	0	.04	-	 < 0.01	1.00E00
regulation of transporter activity (GO:0032409)	40	0	.48	-	 < 0.01	1.00E00
oogenesis (GO:0048477)	7	0	.08	-	 < 0.01	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	7	0	.08	-	 < 0.01	1.00E00
secondary alcohol metabolic process (GO:1902652)	15	0	.18	-	 < 0.01	1.00E00
execution phase of apoptosis (GO:0097194)	8	0	.10	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway (GO:0097193)	16	0	.19	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	12	0	.14	-	 < 0.01	1.00E00
apoptotic signaling pathway (GO:0097190)	28	0	.34	-	 < 0.01	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	9	0	.11	-	 < 0.01	1.00E00
amelogenesis (GO:0097186)	2	0	.02	-	 < 0.01	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	1	0	.01	-	 < 0.01	1.00E00
regulation of protein secretion (GO:0050708)	5	0	.06	-	 < 0.01	1.00E00
erythrocyte differentiation (GO:0030218)	5	0	.06	-	 < 0.01	1.00E00
T cell differentiation (GO:0030217)	6	0	.07	-	 < 0.01	1.00E00
Rac protein signal transduction (GO:0016601)	2	0	.02	-	 < 0.01	1.00E00
circadian rhythm (GO:0007623)	21	0	.25	-	 < 0.01	1.00E00
glutamate metabolic process (GO:0006536)	2	0	.02	-	 < 0.01	1.00E00
Golgi to endosome transport (GO:0006895)	1	0	.01	-	 < 0.01	1.00E00
Golgi to plasma membrane transport (GO:0006893)	23	0	.28	-	 < 0.01	1.00E00
aspartate metabolic process (GO:0006531)	1	0	.01	-	 < 0.01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	17	0	.21	-	 < 0.01	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	17	0	.21	-	 < 0.01	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	18	0	.22	-	 < 0.01	1.00E00
cytoplasmic translational initiation (GO:0002183)	9	0	.11	-	 < 0.01	1.00E00
cytoplasmic translation (GO:0002181)	28	0	.34	-	 < 0.01	1.00E00
cellular response to lipid (GO:0071396)	22	0	.27	-	 < 0.01	1.00E00
arginine metabolic process (GO:0006525)	11	0	.13	-	 < 0.01	1.00E00
regulation of protein stability (GO:0031647)	15	0	.18	-	 < 0.01	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	13	0	.16	-	 < 0.01	1.00E00
regulation of hemopoiesis (GO:1903706)	7	0	.08	-	 < 0.01	1.00E00
negative regulation of molecular function (GO:0044092)	80	0	.97	-	 < 0.01	1.00E00
sensory perception of chemical stimulus (GO:0007606)	4	0	.05	-	 < 0.01	1.00E00
sensory perception of sound (GO:0007605)	9	0	.11	-	 < 0.01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	6	0	.07	-	 < 0.01	1.00E00
visual perception (GO:0007601)	20	0	.24	-	 < 0.01	1.00E00
mitotic DNA replication initiation (GO:1902975)	6	0	.07	-	 < 0.01	1.00E00
sensory perception (GO:0007600)	38	0	.46	-	 < 0.01	1.00E00
intracellular iron ion homeostasis (GO:0006879)	5	0	.06	-	 < 0.01	1.00E00
organic hydroxy compound transport (GO:0015850)	25	0	.30	-	 < 0.01	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	5	0	.06	-	 < 0.01	1.00E00
regulation of cell junction assembly (GO:1901888)	15	0	.18	-	 < 0.01	1.00E00
protein monoubiquitination (GO:0006513)	5	0	.06	-	 < 0.01	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	21	0	.25	-	 < 0.01	1.00E00
intracellular calcium ion homeostasis (GO:0006874)	50	0	.60	-	 < 0.01	1.00E00
regulation of membrane depolarization (GO:0003254)	4	0	.05	-	 < 0.01	1.00E00
negative regulation of protein depolymerization (GO:1901880)	22	0	.27	-	 < 0.01	1.00E00
mitotic DNA replication (GO:1902969)	9	0	.11	-	 < 0.01	1.00E00
cellular response to peptide hormone stimulus (GO:0071375)	22	0	.27	-	 < 0.01	1.00E00
proton transmembrane transport (GO:1902600)	12	0	.14	-	 < 0.01	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	9	0	.11	-	 < 0.01	1.00E00
cell fate commitment (GO:0045165)	55	0	.66	-	 < 0.01	1.00E00
lipid transport (GO:0006869)	77	0	.93	-	 < 0.01	1.00E00
GPI anchor biosynthetic process (GO:0006506)	14	0	.17	-	 < 0.01	1.00E00
axonemal dynein complex assembly (GO:0070286)	7	0	.08	-	 < 0.01	1.00E00
regulation of protein depolymerization (GO:1901879)	25	0	.30	-	 < 0.01	1.00E00
GPI anchor metabolic process (GO:0006505)	15	0	.18	-	 < 0.01	1.00E00
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	18	0	.22	-	 < 0.01	1.00E00
receptor internalization (GO:0031623)	12	0	.14	-	 < 0.01	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	5	0	.06	-	 < 0.01	1.00E00
protein sumoylation (GO:0016925)	10	0	.12	-	 < 0.01	1.00E00
cellular response to growth factor stimulus (GO:0071363)	75	0	.90	-	 < 0.01	1.00E00
peptide transport (GO:0015833)	5	0	.06	-	 < 0.01	1.00E00
oligopeptide transport (GO:0006857)	2	0	.02	-	 < 0.01	1.00E00
tissue remodeling (GO:0048771)	1	0	.01	-	 < 0.01	1.00E00
cell-cell signaling by wnt (GO:0198738)	55	0	.66	-	 < 0.01	1.00E00
regulation of B cell proliferation (GO:0030888)	3	0	.04	-	 < 0.01	1.00E00
regulation of centriole replication (GO:0046599)	4	0	.05	-	 < 0.01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	12	0	.14	-	 < 0.01	1.00E00
axoneme assembly (GO:0035082)	11	0	.13	-	 < 0.01	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	7	0	.08	-	 < 0.01	1.00E00
homologous chromosome segregation (GO:0045143)	7	0	.08	-	 < 0.01	1.00E00
leucine transport (GO:0015820)	1	0	.01	-	 < 0.01	1.00E00
regulation of multicellular organismal development (GO:2000026)	85	0	1.03	-	 < 0.01	6.29E-01
tricarboxylic acid transport (GO:0006842)	3	0	.04	-	 < 0.01	1.00E00
regulation of system process (GO:0044057)	33	0	.40	-	 < 0.01	1.00E00
neuron projection guidance (GO:0097485)	99	0	1.19	-	 < 0.01	6.35E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518)	2	0	.02	-	 < 0.01	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	20	0	.24	-	 < 0.01	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	17	0	.21	-	 < 0.01	1.00E00
regulation of BMP signaling pathway (GO:0030510)	26	0	.31	-	 < 0.01	1.00E00
regulation of lipase activity (GO:0060191)	1	0	.01	-	 < 0.01	1.00E00
glycine transport (GO:0015816)	3	0	.04	-	 < 0.01	1.00E00
mitochondrial transport (GO:0006839)	43	0	.52	-	 < 0.01	1.00E00
meiotic chromosome segregation (GO:0045132)	10	0	.12	-	 < 0.01	1.00E00
aspartate transmembrane transport (GO:0015810)	9	0	.11	-	 < 0.01	1.00E00
inner dynein arm assembly (GO:0036159)	4	0	.05	-	 < 0.01	1.00E00
neurotransmitter transport (GO:0006836)	35	0	.42	-	 < 0.01	1.00E00
outer dynein arm assembly (GO:0036158)	2	0	.02	-	 < 0.01	1.00E00
dicarboxylic acid transport (GO:0006835)	16	0	.19	-	 < 0.01	1.00E00
water transport (GO:0006833)	6	0	.07	-	 < 0.01	1.00E00
protein-RNA complex assembly (GO:0022618)	63	0	.76	-	 < 0.01	1.00E00
BMP signaling pathway (GO:0030509)	14	0	.17	-	 < 0.01	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	12	0	.14	-	 < 0.01	1.00E00
cortical cytoskeleton organization (GO:0030865)	18	0	.22	-	 < 0.01	1.00E00
signal release from synapse (GO:0099643)	32	0	.39	-	 < 0.01	1.00E00
L-amino acid transport (GO:0015807)	16	0	.19	-	 < 0.01	1.00E00
protein localization to extracellular region (GO:0071692)	17	0	.21	-	 < 0.01	1.00E00
neutral amino acid transport (GO:0015804)	20	0	.24	-	 < 0.01	1.00E00
branched-chain amino acid transport (GO:0015803)	1	0	.01	-	 < 0.01	1.00E00
regulation of bone resorption (GO:0045124)	3	0	.04	-	 < 0.01	1.00E00
basic amino acid transport (GO:0015802)	2	0	.02	-	 < 0.01	1.00E00
acidic amino acid transport (GO:0015800)	6	0	.07	-	 < 0.01	1.00E00
iron ion transport (GO:0006826)	12	0	.14	-	 < 0.01	1.00E00
chloride transport (GO:0006821)	35	0	.42	-	 < 0.01	1.00E00
monoatomic anion transport (GO:0006820)	41	0	.49	-	 < 0.01	1.00E00
regulation of anatomical structure morphogenesis (GO:0022603)	74	0	.89	-	 < 0.01	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	7	0	.08	-	 < 0.01	1.00E00
epithelial cell differentiation (GO:0030855)	17	0	.21	-	 < 0.01	1.00E00
glial cell differentiation (GO:0010001)	10	0	.12	-	 < 0.01	1.00E00
cardiac muscle tissue development (GO:0048738)	13	0	.16	-	 < 0.01	1.00E00
protein neddylation (GO:0045116)	7	0	.08	-	 < 0.01	1.00E00
defense response to other organism (GO:0098542)	31	0	.37	-	 < 0.01	1.00E00
phosphate ion transport (GO:0006817)	8	0	.10	-	 < 0.01	1.00E00
sodium ion transport (GO:0006814)	47	0	.57	-	 < 0.01	1.00E00
potassium ion transport (GO:0006813)	86	0	1.04	-	 < 0.01	6.29E-01
striated muscle tissue development (GO:0014706)	13	0	.16	-	 < 0.01	1.00E00
protein localization to cytoskeleton (GO:0044380)	8	0	.10	-	 < 0.01	1.00E00
